cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
SARC	cis	1	rs1000113	chr5:150240076	IRGM	chr5:150226085-150280295:+	0.47	4.23	3.29E-5	Crohn's disease	
SARC	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.52	5.87	1.48E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs10006789	chr4:1330333	CRIPAK	chr4:1385340-1389782:+	0.39	4.77	3.28E-6	Systolic blood pressure	
SARC	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.27	-5.85	1.64E-8	Longevity	
SARC	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.38	-4.96	1.35E-6	Eye color traits	
SARC	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.68	7.4	2.47E-12	Type 2 diabetes	
SARC	cis	1	rs10051804	chr5:150226424	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs10051924	chr5:150226639	IRGM	chr5:150226085-150280295:+	0.5	4.54	9.03E-6	Crohn's disease	
SARC	cis	1	rs10058821	chr5:150226385	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs10058943	chr5:150226586	IRGM	chr5:150226085-150280295:+	0.5	4.54	9.03E-6	Crohn's disease	
SARC	cis	1	rs10065172	chr5:150227998	IRGM	chr5:150226085-150280295:+	0.5	4.54	9.03E-6	Crohn's disease	
SARC	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.44	-5.42	1.49E-7	Rheumatoid arthritis	
SARC	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.37	-7.34	3.51E-12	Common traits (Other)	
SARC	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.38	-7.54	1.02E-12	Common traits (Other)	
SARC	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.36	-7.27	5.41E-12	Common traits (Other)	
SARC	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.56	-8.6	1.19E-15	Homocysteine levels	
SARC	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs10169714	chr2:73808773	ALMS1P	chr2:73872046-73912692:+	0.46	5.88	1.37E-8	Metabolite levels	
SARC	cis	1	rs10175180	chr2:73673123	ALMS1P	chr2:73872046-73912692:+	0.45	5.64	4.81E-8	Metabolite levels	
SARC	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.47	6.05	5.78E-9	Urinary metabolites	
SARC	cis	1	rs10178982	chr2:202227640	CASP8	chr2:202098166-202152434:+	0.26	4.06	6.65E-5	Basal cell carcinoma	
SARC	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.53	6.67	1.82E-10	Metabolite levels	
SARC	cis	1	rs10179134	chr2:73637519	NAT8	chr2:73867850-73869537:-	0.34	4.17	4.27E-5	Metabolite levels	
SARC	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.5	8.19	1.67E-14	Response to antipsychotic treatment	
SARC	cis	1	rs10186501	chr2:73697844	ALMS1P	chr2:73872046-73912692:+	0.45	5.49	1.06E-7	Metabolite levels	
SARC	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.51	5.85	1.63E-8	Metabolite levels	
SARC	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.44	5.38	1.85E-7	Metabolite levels	
SARC	cis	1	rs10189574	chr2:73698518	ALMS1P	chr2:73872046-73912692:+	0.45	5.49	1.06E-7	Metabolite levels	
SARC	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.46	5.54	8.04E-8	Metabolite levels	
SARC	cis	1	rs10193972	chr2:73717656	ALMS1P	chr2:73872046-73912692:+	0.44	5.44	1.35E-7	Metabolite levels	
SARC	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.46	5.84	1.7E-8	Metabolite levels	
SARC	cis	1	rs10208155	chr2:61115039	AHSA2	chr2:61404553-61414058:+	-0.26	-4.86	2.18E-6	Inflammatory skin disease	
SARC	cis	1	rs10208155	chr2:61115039	C2orf74	chr2:61372243-61391964:+	0.44	6.36	1.07E-9	Inflammatory skin disease	
SARC	cis	1	rs10209620	chr2:61173941	C2orf74	chr2:61372243-61391964:+	0.42	6.07	5.1E-9	Inflammatory skin disease	
SARC	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	0.58	6.64	2.2E-10	Diastolic blood pressure	
SARC	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.62	4.39	1.73E-5	Coronary heart disease	
SARC	cis	1	rs10220371	chr14:88501852	ZC3H14	chr14:89029253-89079852:+	0.33	4.24	3.28E-5	Multiple sclerosis	
SARC	cis	1	rs10229552	chr7:99234899	COPS6	chr7:99686583-99689820:+	0.39	4.25	3.04E-5	Blood metabolite levels	
SARC	cis	1	rs10229552	chr7:99234899	CYP3A5	chr7:99245818-99332821:-	0.57	5.21	4.14E-7	Blood metabolite levels	
SARC	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.54	6.6	2.79E-10	Paget's disease	
SARC	cis	1	rs10242455	chr7:99240179	COPS6	chr7:99686583-99689820:+	-0.38	-4.35	2.06E-5	Blood metabolite levels	
SARC	cis	1	rs10242455	chr7:99240179	CYP3A5	chr7:99245818-99332821:-	-0.6	-5.62	5.51E-8	Blood metabolite levels	
SARC	cis	1	rs10242455	chr7:99240179	MCM7	chr7:99690404-99699427:-	-0.31	-4.22	3.54E-5	Blood metabolite levels	
SARC	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.47	-5.24	3.65E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.47	-5.24	3.65E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.47	-8.49	2.35E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.27	4.23	3.34E-5	Multiple sclerosis	
SARC	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.54	-8.26	1.09E-14	Homocysteine levels	
SARC	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.53	-9.04	5.96E-17	Response to antipsychotic treatment	
SARC	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.52	-8.71	5.43E-16	Response to antipsychotic treatment	
SARC	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.56	-9.39	5.66E-18	Response to antipsychotic treatment	
SARC	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.53	-9.04	5.96E-17	Response to antipsychotic treatment	
SARC	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.64	7.05	2.0E-11	Type 2 diabetes	
SARC	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.41E-8	Longevity	
SARC	cis	1	rs10493485	chr1:72071129	NEGR1	chr1:71868626-72748405:-	-0.37	-4.38	1.83E-5	Hemostatic factors and hematological phenotypes	
SARC	cis	1	rs1049564	chr14:20940606	PNP	chr14:20937542-20945246:+	-0.32	-4.8	2.84E-6	Interferon alpha levels in systemic lupus erythematosus	
SARC	cis	1	rs10496191	chr2:73673798	ALMS1P	chr2:73872046-73912692:+	0.45	5.64	4.85E-8	Metabolite levels	
SARC	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.44	5.35	2.13E-7	Metabolite levels	
SARC	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.54	8.95	1.12E-16	Response to antipsychotic treatment	
SARC	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.71	6.48	5.4E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs10505725	chr12:2056363	CACNA2D4	chr12:1901124-2027870:-	-0.22	-4.03	7.64E-5	Obesity-related traits	
SARC	cis	1	rs10514992	chr17:50206330	CA10	chr17:49707675-50237377:-	0.34	4.25	3.04E-5	Gastritis	
SARC	cis	1	rs10518693	chr15:40700022	DISP2	chr15:40650434-40663256:+	0.3	4.27	2.79E-5	Blood metabolite levels;Blood metabolite ratios	
SARC	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.59	-6.91	4.49E-11	Diastolic blood pressure	
SARC	cis	1	rs1057510	chr12:6683287	PEX5	chr12:7341759-7371167:+	-0.31	-4.06	6.81E-5	Myopia (pathological)	
SARC	cis	1	rs1057510	chr12:6683287	TPI1	chr12:6976693-6980108:+	-0.29	-4.44	1.39E-5	Myopia (pathological)	
SARC	cis	1	rs1057510	chr12:6683287	ZNF384	chr12:6775644-6798676:-	-0.33	-4.17	4.25E-5	Myopia (pathological)	
SARC	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.53	8.36	5.49E-15	Homocysteine levels	
SARC	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.27	-4.1	5.59E-5	Hematology traits	
SARC	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.27	4.19	3.88E-5	Multiple sclerosis	
SARC	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.49	6.74	1.22E-10	Height	
SARC	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.27	-4.15	4.63E-5	Hematology traits	
SARC	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.43	-5.23	3.83E-7	Rheumatoid arthritis	
SARC	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.4	-4.92	1.66E-6	Rheumatoid arthritis	
SARC	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.27	4.23	3.38E-5	Multiple sclerosis	
SARC	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.27	4.23	3.38E-5	Multiple sclerosis	
SARC	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.11	5.49E-5	Body mass index	
SARC	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.22	3.51E-5	Body mass index	
SARC	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.37	1.9E-5	Body mass index	
SARC	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.26	-4.04	7.34E-5	Height	
SARC	cis	1	rs10794639	chr16:377367	RGS11	chr16:318310-325914:-	-0.25	-4.19	3.95E-5	Bone mineral density (spine);Bone mineral density	
SARC	cis	1	rs10804111	chr2:202145612	CASP8	chr2:202098166-202152434:+	0.26	4.12	5.27E-5	Melanoma;Esophageal squamous cell carcinoma	
SARC	cis	1	rs10804632	chr3:134294501	CEP63	chr3:134204575-134293852:+	0.33	4.84	2.35E-6	Height	
SARC	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.43	-5.3	2.74E-7	Rheumatoid arthritis	
SARC	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.6	-6.85	6.56E-11	Diastolic blood pressure	
SARC	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.27	4.25	3.05E-5	Multiple sclerosis	
SARC	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.26	4.21	3.65E-5	Multiple sclerosis	
SARC	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.26	4.21	3.65E-5	Multiple sclerosis	
SARC	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.27	4.19	3.9E-5	Multiple sclerosis	
SARC	cis	1	rs10889921	chr1:72045626	NEGR1	chr1:71868626-72748405:-	-0.32	-4.02	7.73E-5	Hemostatic factors and hematological phenotypes	
SARC	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.27	4.38	1.82E-5	Body mass index	
SARC	cis	1	rs10893380	chr11:125311674	C11orf61	chr11:124636394-124670299:-	0.35	4.67	5.05E-6	Schizophrenia	
SARC	cis	1	rs10893380	chr11:125311674	CHEK1	chr11:125495036-125546148:+	0.34	4.32	2.31E-5	Schizophrenia	
SARC	cis	1	rs10901513	chr10:127699936	UROS	chr10:127477148-127511837:-	-0.31	-5.4	1.65E-7	Visceral fat	
SARC	cis	1	rs10901514	chr10:127700066	UROS	chr10:127477148-127511837:-	-0.31	-5.4	1.65E-7	Visceral fat	
SARC	cis	1	rs10901520	chr10:127718837	UROS	chr10:127477148-127511837:-	-0.27	-4.69	4.58E-6	Visceral fat	
SARC	cis	1	rs10906228	chr10:12849790	CDC123	chr10:12237961-12292587:+	0.52	4.3	2.53E-5	Coronary artery aneurysm in Kawasaki disease	
SARC	cis	1	rs10906228	chr10:12849790	PRPF18	chr10:13628939-13697927:+	0.57	4.26	3.02E-5	Coronary artery aneurysm in Kawasaki disease	
SARC	cis	1	rs10906228	chr10:12849790	UPF2	chr10:11962022-12085023:-	0.49	4.25	3.07E-5	Coronary artery aneurysm in Kawasaki disease	
SARC	cis	1	rs10935120	chr3:134233092	CEP63	chr3:134204575-134293852:+	-0.35	-5.22	3.92E-7	Height	
SARC	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.51	-8.41	4.15E-15	Response to antipsychotic treatment	
SARC	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.54	-9.05	5.86E-17	Response to antipsychotic treatment	
SARC	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.53	-8.8	3.12E-16	Response to antipsychotic treatment	
SARC	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.53	-9.08	4.59E-17	Response to antipsychotic treatment	
SARC	cis	1	rs10946198	chr6:167404432	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.24E-5	Crohn's disease	
SARC	cis	1	rs10946199	chr6:167404492	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.24E-5	Crohn's disease	
SARC	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.26	4.57	7.81E-6	Blood metabolite levels	
SARC	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.38	4.03	7.45E-5	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs11067231	chr12:109993603	MYO1H	chr12:109826524-109886176:+	0.3	4.22	3.45E-5	HDL cholesterol	
SARC	cis	1	rs11070798	chr15:50883263	SPPL2A	chr15:50999739-51057910:-	0.25	4.1	5.66E-5	QT interval	
SARC	cis	1	rs11072603	chr15:76881138	SCAPER	chr15:76640529-77197744:-	-0.23	-5.03	9.59E-7	Blood metabolite levels	
SARC	cis	1	rs11088226	chr21:33925531	TCP10L	chr21:33947152-33957845:-	-0.41	-4.06	6.82E-5	Gastritis	
SARC	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.26	-5.58	6.65E-8	Longevity	
SARC	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.38	4.08	6.26E-5	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.62	-8.48	2.61E-15	Renal function-related traits (BUN)	
SARC	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.5	-6.87	5.62E-11	Renal function-related traits (BUN)	
SARC	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.39	-5.32	2.47E-7	Body mass index	
SARC	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.41E-8	Longevity	
SARC	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.25	-5.2	4.38E-7	Longevity	
SARC	cis	1	rs111315781	chr2:201738724	CFLAR	chr2:201980816-202029001:+	-0.44	-5.63	5.26E-8	Triptolide cytotoxicity	
SARC	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.97	-8.8	3.16E-16	Triptolide cytotoxicity	
SARC	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.34	-6.77	1.03E-10	Kawasaki disease	
SARC	cis	1	rs1114380	chr2:73804708	ALMS1P	chr2:73872046-73912692:+	0.46	5.84	1.69E-8	Metabolite levels	
SARC	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.36	7.07	1.79E-11	Common traits (Other)	
SARC	cis	1	rs111596617	chr6:26191678	HIST1H3E	chr6:26224427-26226589:+	0.58	5.46	1.19E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs11171846	chr12:56828056	RPS26	chr12:56435686-56438005:+	-0.42	-4.51	1.03E-5	Immune reponse to smallpox (secreted IFN-alpha)	
SARC	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.27	4.25	3.13E-5	Multiple sclerosis	
SARC	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.27	4.2	3.85E-5	Multiple sclerosis	
SARC	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.27	4.18	4.08E-5	Multiple sclerosis	
SARC	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.27	4.18	4.08E-5	Multiple sclerosis	
SARC	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.27	4.23	3.38E-5	Multiple sclerosis	
SARC	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.27	4.21	3.62E-5	Multiple sclerosis	
SARC	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.26	4.1	5.64E-5	Multiple sclerosis	
SARC	cis	1	rs1117367	chr15:76872330	SCAPER	chr15:76640529-77197744:-	-0.22	-4.91	1.75E-6	Blood metabolite levels	
SARC	cis	1	rs11185790	chr10:91372533	FLJ37201	chr10:91451057-91457685:-	0.37	4.2	3.76E-5	Metabolic traits	
SARC	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.7	6.44	6.6E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-0.59	-6.43	7.17E-10	Chronic obstructive pulmonary disease-related biomarkers	
SARC	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.56	-5.79	2.2E-8	Chronic obstructive pulmonary disease-related biomarkers	
SARC	cis	1	rs11209801	chr1:72067202	NEGR1	chr1:71868626-72748405:-	-0.36	-4.33	2.21E-5	Hemostatic factors and hematological phenotypes	
SARC	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.56	-8.58	1.36E-15	Homocysteine levels	
SARC	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.27	2.84E-5	Body mass index	
SARC	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.36	1.91E-5	Body mass index	
SARC	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.37	1.91E-5	Body mass index	
SARC	cis	1	rs11227284	chr11:65503224	CTSW	chr11:65647284-65651212:+	-0.28	-4.68	4.82E-6	Systemic lupus erythematosus	
SARC	cis	1	rs11228927	chr11:56930363	P2RX3	chr11:57105949-57137548:+	0.49	4.36	1.91E-5	Low high density lipoprotein cholesterol levels	
SARC	cis	1	rs11242	chr3:53125922	RFT1	chr3:53122503-53164470:-	0.26	4.02	7.75E-5	Height	
SARC	cis	1	rs1125203	chr3:41760895	ULK4	chr3:41288091-42003660:-	0.62	7.01	2.55E-11	Diastolic blood pressure	
SARC	cis	1	rs112751982	chr6:26191958	HIST1H3E	chr6:26224427-26226589:+	0.58	5.46	1.19E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs1130650	chr14:20940626	PNP	chr14:20937542-20945246:+	-0.31	-4.66	5.35E-6	Interferon alpha levels in systemic lupus erythematosus	
SARC	cis	1	rs113179672	chr12:117327241	FBXW8	chr12:117348761-117470180:+	-0.35	-4.23	3.34E-5	Subcortical brain region volumes	
SARC	cis	1	rs113205216	chr12:117326943	FBXW8	chr12:117348761-117470180:+	-0.35	-4.25	3.03E-5	Subcortical brain region volumes	
SARC	cis	1	rs113688220	chr10:45175132	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs1138273	chr3:134261437	CEP63	chr3:134204575-134293852:+	0.34	4.86	2.11E-6	Height	
SARC	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	0.35	4.25	3.13E-5	Heschl's gyrus morphology	
SARC	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.31	4.72	4.13E-6	Body mass index	
SARC	cis	1	rs11592342	chr10:45164337	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs11596402	chr10:45189329	ALOX5	chr10:45869629-45941561:+	0.2	4.23	3.41E-5	Parkinson's disease	
SARC	cis	1	rs11598037	chr10:45246766	ALOX5	chr10:45869629-45941561:+	0.21	4.24	3.28E-5	Parkinson's disease	
SARC	cis	1	rs11621351	chr14:55616740	MAPK1IP1L	chr14:55518362-55536912:+	0.27	4.07	6.4E-5	Protein biomarker	
SARC	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.37	7.3	4.54E-12	Common traits (Other)	
SARC	cis	1	rs11633958	chr15:78862064	CHRNA5	chr15:78857906-78886458:+	-0.26	-4.07	6.48E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
SARC	cis	1	rs11650372	chr17:45721795	C17orf57	chr17:45401142-45518675:+	0.29	4.68	4.96E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.56	-8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.57	8.67	7.25E-16	Eye color traits	
SARC	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.45	5.38	1.8E-7	Metabolite levels	
SARC	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.61	-9.61	1.25E-18	Body mass index	
SARC	cis	1	rs1167827	chr7:75163169	STAG3L1	chr7:74988447-75026250:+	-0.3	-4.93	1.56E-6	Body mass index	
SARC	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.41	5.7	3.61E-8	Body mass index	
SARC	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.4	5.58	6.65E-8	Body mass index	
SARC	cis	1	rs11696501	chr20:44124523	WFDC3	chr20:44402847-44420547:-	0.38	4.47	1.22E-5	Brain structure	
SARC	cis	1	rs11696747	chr20:48128119	STAU1	chr20:47729878-47805288:-	-0.34	-4.46	1.29E-5	Schizophrenia	
SARC	cis	1	rs11698535	chr20:48123066	STAU1	chr20:47729878-47805288:-	-0.36	-4.62	6.37E-6	Schizophrenia	
SARC	cis	1	rs11701627	chr21:33927794	TCP10L	chr21:33947152-33957845:-	-0.42	-4.25	3.11E-5	Gastritis	
SARC	cis	1	rs11706117	chr3:134212526	CEP63	chr3:134204575-134293852:+	0.37	5.31	2.53E-7	Height	
SARC	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.3	4.12	5.2E-5	Height	
SARC	cis	1	rs11708531	chr3:134224902	CEP63	chr3:134204575-134293852:+	0.36	5.34	2.19E-7	Height	
SARC	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.32	4.17	4.24E-5	Cognitive performance	
SARC	cis	1	rs11733284	chr4:48028097	CNGA1	chr4:47937996-48018610:-	0.32	4.21	3.58E-5	Renal underexcretion gout;Gout	
SARC	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.67	7.3	4.42E-12	Type 2 diabetes	
SARC	cis	1	rs11741861	chr5:150277909	IRGM	chr5:150226085-150280295:+	-0.47	-4.04	7.32E-5	Crohn's disease	
SARC	cis	1	rs11743488	chr5:150279218	IRGM	chr5:150226085-150280295:+	0.48	4.15	4.73E-5	Crohn's disease	
SARC	cis	1	rs11748151	chr5:150226292	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs11748158	chr5:150226345	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs11749391	chr5:150229066	IRGM	chr5:150226085-150280295:+	0.48	4.45	1.34E-5	Crohn's disease	
SARC	cis	1	rs11754744	chr6:26202605	HIST1H3E	chr6:26224427-26226589:+	0.58	5.5	9.69E-8	Renal underexcretion gout;Gout	
SARC	cis	1	rs11755210	chr6:26202768	HIST1H3E	chr6:26224427-26226589:+	0.58	5.5	9.69E-8	Renal underexcretion gout;Gout	
SARC	cis	1	rs11758351	chr6:26203910	HIST1H3E	chr6:26224427-26226589:+	0.54	5.16	5.38E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.51	-7.96	7.21E-14	Response to antipsychotic treatment	
SARC	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.53	-8.65	8.34E-16	Response to antipsychotic treatment	
SARC	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.54	-8.99	8.36E-17	Response to antipsychotic treatment	
SARC	cis	1	rs11813028	chr10:45176155	ALOX5	chr10:45869629-45941561:+	0.21	4.13	5.14E-5	Parkinson's disease	
SARC	cis	1	rs11813782	chr10:45165661	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs11818158	chr10:45166268	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs11819624	chr10:45174223	ALOX5	chr10:45869629-45941561:+	0.2	4.17	4.25E-5	Parkinson's disease	
SARC	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	0.35	4.25	3.13E-5	Heschl's gyrus morphology	
SARC	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.29	-4.69	4.58E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs11880333	chr19:49144790	RPL18	chr19:49118588-49122433:-	-0.32	-4.13	5.02E-5	Elevated serum carcinoembryonic antigen levels	
SARC	cis	1	rs11880333	chr19:49144790	SEC1	chr19:49141296-49185501:+	-0.58	-5.13	6.01E-7	Elevated serum carcinoembryonic antigen levels	
SARC	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.45	8.89	1.64E-16	Schizophrenia	
SARC	cis	1	rs11893881	chr2:73824373	ALMS1P	chr2:73872046-73912692:+	0.42	5.18	4.85E-7	Metabolite levels	
SARC	cis	1	rs11894344	chr2:71019243	FAM136A	chr2:70523109-70529220:-	0.61	4.58	7.57E-6	Severe influenza A (H1N1) infection	
SARC	cis	1	rs11894344	chr2:71019243	SNRPG	chr2:70508510-70520869:-	0.53	4.88	1.93E-6	Severe influenza A (H1N1) infection	
SARC	cis	1	rs11894344	chr2:71019243	TEX261	chr2:71213070-71222001:-	0.68	4.7	4.36E-6	Severe influenza A (H1N1) infection	
SARC	cis	1	rs11894344	chr2:71019243	TIA1	chr2:70436577-70475779:-	0.51	4.8	2.82E-6	Severe influenza A (H1N1) infection	
SARC	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.53	6.49	4.97E-10	Metabolite levels	
SARC	cis	1	rs11899902	chr2:73631564	ALMS1P	chr2:73872046-73912692:+	0.53	6.68	1.69E-10	Metabolite levels	
SARC	cis	1	rs11901272	chr2:73720444	ALMS1P	chr2:73872046-73912692:+	0.44	5.45	1.25E-7	Metabolite levels	
SARC	cis	1	rs11903916	chr2:73815328	ALMS1P	chr2:73872046-73912692:+	0.46	5.79	2.28E-8	Metabolite levels	
SARC	cis	1	rs11919350	chr3:134235970	CEP63	chr3:134204575-134293852:+	-0.34	-4.95	1.4E-6	Height	
SARC	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.53	5.47	1.16E-7	Diastolic blood pressure	
SARC	cis	1	rs11927068	chr3:134266321	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.3	-4.03	7.65E-5	Height	
SARC	cis	1	rs11928499	chr3:134232350	CEP63	chr3:134204575-134293852:+	-0.36	-5.26	3.31E-7	Height	
SARC	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.82E-11	Diastolic blood pressure	
SARC	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	0.82	11.27	8.14E-24	Educational attainment (years of education)	
SARC	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.45	4.67	5.04E-6	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.45	4.67	5.04E-6	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.45	4.67	5.04E-6	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs12051546	chr17:50205253	CA10	chr17:49707675-50237377:-	0.34	4.25	3.04E-5	Gastritis	
SARC	cis	1	rs12052257	chr2:202241594	CASP8	chr2:202098166-202152434:+	-0.28	-4.31	2.41E-5	Basal cell carcinoma	
SARC	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.58	-4.4	1.62E-5	Coronary heart disease	
SARC	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.45	4.71	4.34E-6	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.45	4.67	5.04E-6	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs12148786	chr15:76800362	SCAPER	chr15:76640529-77197744:-	-0.22	-5.03	9.82E-7	Blood metabolite levels	
SARC	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.51	-8.41	4.15E-15	Response to antipsychotic treatment	
SARC	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.51	5.76	2.68E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs12185102	chr15:75352201	SCAMP5	chr15:75287901-75313836:+	0.38	4.71	4.27E-6	Blood trace element (Zn levels)	
SARC	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.55	-9	7.97E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.55	-9.31	9.4E-18	Response to antipsychotic treatment	
SARC	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.53	-8.65	8.34E-16	Response to antipsychotic treatment	
SARC	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.54	-9.17	2.49E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.52	-8.71	5.68E-16	Response to antipsychotic treatment	
SARC	cis	1	rs12196937	chr6:49382808	CENPQ	chr6:49431096-49460820:+	-0.25	-4.41	1.57E-5	Folate pathway vitamin levels	
SARC	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.53	-8.88	1.77E-16	Response to antipsychotic treatment	
SARC	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.53	-8.88	1.77E-16	Response to antipsychotic treatment	
SARC	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.53	-8.62	9.91E-16	Response to antipsychotic treatment	
SARC	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.53	-8.65	8.34E-16	Response to antipsychotic treatment	
SARC	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.51	-8.42	3.91E-15	Response to antipsychotic treatment	
SARC	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.51	-8.19	1.7E-14	Response to antipsychotic treatment	
SARC	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.51	-8.41	4.15E-15	Response to antipsychotic treatment	
SARC	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.25	-4.45	1.3E-5	Folate pathway vitamin levels	
SARC	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.53	-8.98	8.98E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.53	-8.98	8.98E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.54	-9.28	1.21E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.53	-9.09	4.44E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.55	-9.16	2.74E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.53	-9.05	5.88E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.53	-8.88	1.77E-16	Response to antipsychotic treatment	
SARC	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.53	-9.08	4.59E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.55	-9.22	1.79E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.55	-9.16	2.74E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.54	-9.05	5.66E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.55	-9.22	1.79E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.51	-8.38	4.89E-15	Response to antipsychotic treatment	
SARC	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.55	-9.24	1.53E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.53	-9.08	4.59E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.55	-9.35	7.57E-18	Response to antipsychotic treatment	
SARC	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.55	-9.35	7.54E-18	Response to antipsychotic treatment	
SARC	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.46	-4.38	1.78E-5	Chronic obstructive pulmonary disease-related biomarkers	
SARC	cis	1	rs12287832	chr11:65553492	CTSW	chr11:65647284-65651212:+	-0.26	-4.35	2.07E-5	Systemic lupus erythematosus	
SARC	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.35	4.28	2.75E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.25	3.05E-5	Body mass index	
SARC	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.25	-4.04	7.16E-5	Body mass index	
SARC	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.25	-4.04	7.16E-5	Body mass index	
SARC	cis	1	rs12441433	chr15:76816015	SCAPER	chr15:76640529-77197744:-	-0.22	-4.95	1.42E-6	Blood metabolite levels	
SARC	cis	1	rs12443137	chr15:76840832	SCAPER	chr15:76640529-77197744:-	-0.21	-4.87	2.02E-6	Blood metabolite levels	
SARC	cis	1	rs12459469	chr19:53667913	ZNF665	chr19:53666552-53696619:-	-0.25	-4.07	6.53E-5	Yu-Zhi constitution type in type 2 diabetes	
SARC	cis	1	rs12483517	chr21:42691920	FAM3B	chr21:42676177-42729654:+	0.37	4.05	6.85E-5	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
SARC	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs12490835	chr3:134223730	CEP63	chr3:134204575-134293852:+	0.35	5.13	5.96E-7	Height	
SARC	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.25	3.05E-5	Body mass index	
SARC	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.19	4.03E-5	Body mass index	
SARC	cis	1	rs12564885	chr1:72063310	NEGR1	chr1:71868626-72748405:-	-0.36	-4.35	2.04E-5	Hemostatic factors and hematological phenotypes	
SARC	cis	1	rs12570188	chr10:100855702	C10orf28	chr10:99894381-100004653:+	-0.62	-4.83	2.47E-6	Asthma (childhood onset)	
SARC	cis	1	rs12570188	chr10:100855702	HPS1	chr10:100175956-100206704:-	-0.46	-4.09	6.03E-5	Asthma (childhood onset)	
SARC	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.39	-5.07	7.9E-7	Forced vital capacity	
SARC	cis	1	rs12589282	chr14:22937656	ABHD4	chr14:23067147-23081257:+	-0.29	-4.38	1.79E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	
SARC	cis	1	rs12589282	chr14:22937656	C14orf119	chr14:23564788-23569664:+	-0.25	-4.07	6.33E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	
SARC	cis	1	rs12594212	chr15:76802014	SCAPER	chr15:76640529-77197744:-	-0.21	-4.88	1.93E-6	Blood metabolite levels	
SARC	cis	1	rs12594541	chr15:76834368	SCAPER	chr15:76640529-77197744:-	-0.21	-4.87	2.02E-6	Blood metabolite levels	
SARC	cis	1	rs12601384	chr17:50199900	CA10	chr17:49707675-50237377:-	0.34	4.05	6.9E-5	Gastritis	
SARC	cis	1	rs12608544	chr19:49136651	RPL13A	chr19:49990865-49995562:+	-0.31	-4.14	4.92E-5	Elevated serum carcinoembryonic antigen levels	
SARC	cis	1	rs12608544	chr19:49136651	SEC1	chr19:49141296-49185501:+	-0.61	-5.01	1.06E-6	Elevated serum carcinoembryonic antigen levels	
SARC	cis	1	rs12620618	chr2:232877509	COPS7B	chr2:232646445-232673434:+	0.72	4.84	2.33E-6	Height	
SARC	cis	1	rs12620618	chr2:232877509	DIS3L2	chr2:232826293-233201907:+	0.63	4.44	1.42E-5	Height	
SARC	cis	1	rs12637751	chr3:134266124	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.58	6.51	4.58E-10	Diastolic blood pressure	
SARC	cis	1	rs12652003	chr5:150231945	IRGM	chr5:150226085-150280295:+	0.53	4.54	9.17E-6	Crohn's disease	
SARC	cis	1	rs12656538	chr5:150251380	IRGM	chr5:150226085-150280295:+	0.54	4.48	1.16E-5	Crohn's disease	
SARC	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.55	-9.17	2.48E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.53	-9.09	4.44E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.52	8.52	1.96E-15	Response to antipsychotic treatment	
SARC	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.53	9.11	3.75E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.53	-9.05	5.88E-17	Response to antipsychotic treatment	
SARC	cis	1	rs12677676	chr8:126502526	NDUFB9	chr8:125551343-125580751:+	-0.25	-4.11	5.51E-5	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
SARC	cis	1	rs12677676	chr8:126502526	TATDN1	chr8:125500735-125551329:-	-0.28	-4.04	7.19E-5	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
SARC	cis	1	rs1282551	chr6:153009944	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs12828040	chr12:7326541	PEX5	chr12:7341759-7371167:+	0.27	4.52	9.93E-6	IgG glycosylation	
SARC	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.27	-4.57	7.96E-6	IgG glycosylation	
SARC	cis	1	rs12898259	chr15:75369780	SCAMP5	chr15:75287901-75313836:+	0.35	4.37	1.83E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs12898430	chr15:76874923	SCAPER	chr15:76640529-77197744:-	-0.23	-5.05	9.02E-7	Blood metabolite levels	
SARC	cis	1	rs12901243	chr15:75374233	SCAMP5	chr15:75287901-75313836:+	0.35	4.37	1.83E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs1290296	chr6:153010088	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs12903201	chr15:75370776	SCAMP5	chr15:75287901-75313836:+	0.35	4.37	1.83E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs12910644	chr15:75358388	SCAMP5	chr15:75287901-75313836:+	0.37	4.42	1.53E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.57	8.53	1.87E-15	Eye color traits	
SARC	cis	1	rs12985467	chr19:53667357	ZNF665	chr19:53666552-53696619:-	-0.25	-4.07	6.53E-5	Yu-Zhi constitution type in type 2 diabetes	
SARC	cis	1	rs12986080	chr19:53667351	ZNF665	chr19:53666552-53696619:-	-0.25	-4.07	6.53E-5	Yu-Zhi constitution type in type 2 diabetes	
SARC	cis	1	rs13008299	chr2:29247997	TRMT61B	chr2:29072690-29093175:-	-0.34	-4.51	1.05E-5	Diastolic blood pressure (alcohol consumption interaction)	
SARC	cis	1	rs13014235	chr2:202215492	CASP8	chr2:202098166-202152434:+	0.28	4.31	2.37E-5	Basal cell carcinoma	
SARC	cis	1	rs13016963	chr2:202162811	CASP8	chr2:202098166-202152434:+	0.28	4.3	2.46E-5	Melanoma;Esophageal squamous cell carcinoma	
SARC	cis	1	rs13033143	chr2:61161095	AHSA2	chr2:61404553-61414058:+	-0.25	-4.53	9.29E-6	Inflammatory skin disease	
SARC	cis	1	rs13033143	chr2:61161095	C2orf74	chr2:61372243-61391964:+	0.44	6.41	7.9E-10	Inflammatory skin disease	
SARC	cis	1	rs13039739	chr20:48125015	STAU1	chr20:47729878-47805288:-	-0.35	-4.41	1.54E-5	Schizophrenia	
SARC	cis	1	rs13059720	chr3:134242021	CEP63	chr3:134204575-134293852:+	-0.33	-4.83	2.47E-6	Height	
SARC	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.26	-5.37	1.92E-7	Longevity	
SARC	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs13071551	chr3:134310867	CEP63	chr3:134204575-134293852:+	-0.34	-4.88	2.0E-6	Height	
SARC	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.25	-5.2	4.43E-7	Longevity	
SARC	cis	1	rs13081177	chr3:134289860	CEP63	chr3:134204575-134293852:+	-0.34	-4.84	2.34E-6	Height	
SARC	cis	1	rs13081688	chr3:134259954	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-0.62	-7.07	1.78E-11	Diastolic blood pressure	
SARC	cis	1	rs13087875	chr3:134261123	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs13089966	chr3:134279197	CEP63	chr3:134204575-134293852:+	-0.34	-4.91	1.7E-6	Height	
SARC	cis	1	rs13090969	chr3:134307257	CEP63	chr3:134204575-134293852:+	-0.34	-4.88	2.0E-6	Height	
SARC	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.26	-5.48	1.12E-7	Longevity	
SARC	cis	1	rs13096604	chr3:134250099	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.49	-5.51	9.59E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs13120847	chr4:48030036	CNGA1	chr4:47937996-48018610:-	0.31	4.04	7.2E-5	Renal underexcretion gout;Gout	
SARC	cis	1	rs13125949	chr4:48026560	CNGA1	chr4:47937996-48018610:-	0.32	4.12	5.19E-5	Renal underexcretion gout;Gout	
SARC	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.48	-5.38	1.81E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.31	4.1	5.72E-5	Renal underexcretion gout;Gout	
SARC	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.32	4.12	5.19E-5	Renal underexcretion gout;Gout	
SARC	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.53	-8.65	8.34E-16	Response to antipsychotic treatment	
SARC	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.55	-8.95	1.12E-16	Response to antipsychotic treatment	
SARC	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.53	-8.91	1.47E-16	Response to antipsychotic treatment	
SARC	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.5	-8.31	7.55E-15	Response to antipsychotic treatment	
SARC	cis	1	rs1322512	chr6:152947953	FBXO5	chr6:153291660-153304740:-	0.19	4.14	4.9E-5	Tonometry	
SARC	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.85	15.23	7.37E-37	Bone mineral density	
SARC	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.83	14.95	6.19E-36	Bone mineral density	
SARC	cis	1	rs13271368	chr8:126506140	NDUFB9	chr8:125551343-125580751:+	-0.25	-4.05	6.94E-5	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
SARC	cis	1	rs13271368	chr8:126506140	TATDN1	chr8:125500735-125551329:-	-0.29	-4.02	7.78E-5	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
SARC	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.28	5.96	9.25E-9	Longevity	
SARC	cis	1	rs13322305	chr3:134310791	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.45E-6	Height	
SARC	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.56	5.84	1.75E-8	Diastolic blood pressure	
SARC	cis	1	rs13361189	chr5:150223387	IRGM	chr5:150226085-150280295:+	0.52	4.69	4.58E-6	Crohn's disease	
SARC	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.53	-9.08	4.59E-17	Response to antipsychotic treatment	
SARC	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.55	-9.16	2.74E-17	Response to antipsychotic treatment	
SARC	cis	1	rs13383871	chr2:73631779	ALMS1P	chr2:73872046-73912692:+	0.51	6.4	8.32E-10	Metabolite levels	
SARC	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.45	5.38	1.85E-7	Metabolite levels	
SARC	cis	1	rs1341759	chr6:26195502	HIST1H3E	chr6:26224427-26226589:+	0.58	5.46	1.23E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.44	5.27	3.05E-7	Metabolite levels	
SARC	cis	1	rs13428235	chr2:73633430	ALMS1P	chr2:73872046-73912692:+	0.53	6.68	1.69E-10	Metabolite levels	
SARC	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.46	5.84	1.7E-8	Metabolite levels	
SARC	cis	1	rs13432605	chr2:73810981	ALMS1P	chr2:73872046-73912692:+	0.47	5.89	1.32E-8	Metabolite levels	
SARC	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.25	-4.21	3.62E-5	Cognitive function	
SARC	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.26	-4.51	1.01E-5	Cognitive function	
SARC	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.26	-4.36	1.94E-5	Cognitive function	
SARC	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.25	-4.24	3.21E-5	Cognitive function	
SARC	cis	1	rs1357762	chr3:134264859	CEP63	chr3:134204575-134293852:+	0.33	4.86	2.16E-6	Height	
SARC	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.59	-7.24	6.58E-12	Type 2 diabetes	
SARC	cis	1	rs1383373	chr10:45165923	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs1391708	chr12:57305580	TIMELESS	chr12:56810157-56843200:-	-0.26	-4.09	5.83E-5	Airway wall thickness	
SARC	cis	1	rs1395297	chr15:50878509	SPPL2A	chr15:50999739-51057910:-	-0.28	-4.51	1.01E-5	QT interval	
SARC	cis	1	rs1403284	chr2:73726662	ALMS1P	chr2:73872046-73912692:+	-0.44	-5.46	1.22E-7	Metabolite levels	
SARC	cis	1	rs140330585	chr15:78866445	CHRNA5	chr15:78857906-78886458:+	-0.26	-4.13	4.96E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
SARC	cis	1	rs1405694	chr6:152946561	FBXO5	chr6:153291660-153304740:-	0.2	4.25	3.08E-5	Tonometry	
SARC	cis	1	rs1406947	chr20:33969530	CPNE1	chr20:34213968-34262539:-	0.3	4.23	3.38E-5	Height	
SARC	cis	1	rs1407488	chr6:152945777	FBXO5	chr6:153291660-153304740:-	0.2	4.23	3.35E-5	Tonometry	
SARC	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.53	-8.98	8.98E-17	Response to antipsychotic treatment	
SARC	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.63	6.95	3.64E-11	Type 2 diabetes	
SARC	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.63	7.1	1.45E-11	Type 2 diabetes	
SARC	cis	1	rs1428555	chr5:150257391	IRGM	chr5:150226085-150280295:+	-0.46	-4.29	2.62E-5	Crohn's disease	
SARC	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.25	5.37	1.93E-7	Longevity	
SARC	cis	1	rs146009840	chr15:78906177	CHRNA5	chr15:78857906-78886458:+	-0.27	-4.07	6.45E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
SARC	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.3	4.13	4.97E-5	Height	
SARC	cis	1	rs1498718	chr3:134205920	CEP63	chr3:134204575-134293852:+	0.36	5.28	2.88E-7	Height	
SARC	cis	1	rs1503059	chr17:50204456	CA10	chr17:49707675-50237377:-	0.33	4.22	3.49E-5	Gastritis	
SARC	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.46	-7	2.7E-11	Ankylosing spondylitis	
SARC	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.43	5.36	1.96E-7	Ankylosing spondylitis	
SARC	cis	1	rs1534025	chr3:134313304	CEP63	chr3:134204575-134293852:+	-0.34	-4.88	2.0E-6	Height	
SARC	cis	1	rs1534026	chr3:134284767	CEP63	chr3:134204575-134293852:+	0.34	4.93	1.54E-6	Height	
SARC	cis	1	rs1534471	chr2:73647508	ALMS1P	chr2:73872046-73912692:+	0.44	5.61	5.81E-8	Metabolite levels	
SARC	cis	1	rs1540927	chr20:33931344	CPNE1	chr20:34213968-34262539:-	0.32	4.48	1.15E-5	Height	
SARC	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.66	7.43	1.98E-12	Type 2 diabetes	
SARC	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.58	6.52	4.35E-10	Diastolic blood pressure	
SARC	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.24	-4.23	3.34E-5	Blood metabolite levels	
SARC	cis	1	rs1570004	chr20:33958253	CPNE1	chr20:34213968-34262539:-	0.3	4.24	3.23E-5	Height	
SARC	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.53	-9.03	6.7E-17	Response to antipsychotic treatment	
SARC	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.53	-8.98	8.98E-17	Response to antipsychotic treatment	
SARC	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.27	4.2	3.85E-5	Multiple sclerosis	
SARC	cis	1	rs1600615	chr10:45167509	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.42	-5.23	3.78E-7	Rheumatoid arthritis	
SARC	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.62	-6.86	6.04E-11	Diastolic blood pressure	
SARC	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.6	-6.95	3.55E-11	Diastolic blood pressure	
SARC	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.6	6.95	3.55E-11	Diastolic blood pressure	
SARC	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-0.61	-7.09	1.56E-11	Diastolic blood pressure	
SARC	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.59	-6.91	4.49E-11	Diastolic blood pressure	
SARC	cis	1	rs1631457	chr6:152946514	FBXO5	chr6:153291660-153304740:-	0.19	4.12	5.33E-5	Tonometry	
SARC	cis	1	rs164106	chr17:74290566	TSEN54	chr17:73512609-73520820:+	0.27	4.15	4.65E-5	White matter hyperintensities in ischemic stroke	
SARC	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.51	4.37	1.85E-5	Rheumatoid arthritis	
SARC	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.54	-9.28	1.21E-17	Response to antipsychotic treatment	
SARC	cis	1	rs16891378	chr6:26188864	HIST1H3E	chr6:26224427-26226589:+	0.54	5.17	5.05E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs16891397	chr6:26200256	HIST1H3E	chr6:26224427-26226589:+	0.59	5.51	9.47E-8	Renal underexcretion gout;Gout	
SARC	cis	1	rs16891401	chr6:26202337	HIST1H3E	chr6:26224427-26226589:+	0.59	5.49	1.03E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs16891405	chr6:26204506	HIST1H3E	chr6:26224427-26226589:+	0.55	5.18	4.8E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs16952611	chr18:48382668	MRO	chr18:48321491-48351754:-	-0.4	-4.52	9.77E-6	Entorhinal cortical thickness	
SARC	cis	1	rs16954776	chr13:98700617	FARP1	chr13:98794816-99102016:+	0.6	4.57	7.88E-6	Smooth-surface caries	
SARC	cis	1	rs16954776	chr13:98700617	IPO5	chr13:98605929-98676549:+	0.83	5.88	1.43E-8	Smooth-surface caries	
SARC	cis	1	rs16954776	chr13:98700617	STK24	chr13:99102455-99229396:-	0.74	4.76	3.47E-6	Smooth-surface caries	
SARC	cis	1	rs16974263	chr19:40913539	PLD3	chr19:40854332-40884389:+	0.35	4.29	2.63E-5	Otitis media (recurrent);Otitis media (chronic);Otitis media	
SARC	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.48	-5.38	1.79E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.48	-5.39	1.75E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.48	-5.39	1.75E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.48	-5.38	1.81E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.49	-5.45	1.27E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.49	-5.48	1.12E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.45	4.67	5.04E-6	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.64	7.47	1.6E-12	Diastolic blood pressure	
SARC	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.59	6.78	9.49E-11	Diastolic blood pressure	
SARC	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.58	6.45	6.21E-10	Diastolic blood pressure	
SARC	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.58	6.51	4.58E-10	Diastolic blood pressure	
SARC	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.58	6.52	4.35E-10	Diastolic blood pressure	
SARC	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	0.62	7.13	1.22E-11	Diastolic blood pressure	
SARC	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.24	3.2E-5	Body mass index	
SARC	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.25	-4.03	7.41E-5	Body mass index	
SARC	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.2	3.86E-5	Body mass index	
SARC	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.37	7.29	4.68E-12	Common traits (Other)	
SARC	cis	1	rs17108018	chr12:70736946	KCNMB4	chr12:70760062-70824977:+	0.31	4.17	4.23E-5	Amyotrophic lateral sclerosis (age of onset)	
SARC	cis	1	rs17111376	chr5:150226899	IRGM	chr5:150226085-150280295:+	0.5	4.54	9.03E-6	Crohn's disease	
SARC	cis	1	rs1713422	chr14:20940834	PNP	chr14:20937542-20945246:+	-0.32	-4.7	4.46E-6	Interferon alpha levels in systemic lupus erythematosus	
SARC	cis	1	rs17147709	chr11:84593750	TMEM126B	chr11:85339662-85347576:+	0.56	4.58	7.58E-6	Attention function in attention deficit hyperactive disorder	
SARC	cis	1	rs17161692	chr7:98953863	CYP3A5	chr7:99245818-99332821:-	-0.63	-5.57	7.07E-8	Blood metabolite levels	
SARC	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.5	4.83	2.47E-6	Age-related hearing impairment (interaction)	
SARC	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.6	-6.95	3.55E-11	Diastolic blood pressure	
SARC	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.62	-6.86	6.04E-11	Diastolic blood pressure	
SARC	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.61	-7.09	1.56E-11	Diastolic blood pressure	
SARC	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.6	-6.85	6.56E-11	Diastolic blood pressure	
SARC	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-0.6	-7.05	1.98E-11	Diastolic blood pressure	
SARC	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.6	-6.89	5.08E-11	Diastolic blood pressure	
SARC	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.6	-6.93	4.06E-11	Diastolic blood pressure	
SARC	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.6	6.95	3.55E-11	Diastolic blood pressure	
SARC	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.6	6.95	3.55E-11	Diastolic blood pressure	
SARC	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-0.6	-6.85	6.56E-11	Diastolic blood pressure	
SARC	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.58	6.72	1.4E-10	Diastolic blood pressure	
SARC	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.59	-6.91	4.49E-11	Diastolic blood pressure	
SARC	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-0.6	-6.85	6.56E-11	Diastolic blood pressure	
SARC	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-0.6	-6.9	4.75E-11	Diastolic blood pressure	
SARC	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-0.59	-6.99	2.88E-11	Diastolic blood pressure	
SARC	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-0.61	-7.08	1.7E-11	Diastolic blood pressure	
SARC	cis	1	rs1716984	chr3:41965532	ULK4	chr3:41288091-42003660:-	-0.61	-7.09	1.6E-11	Diastolic blood pressure	
SARC	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.62	-6.82	7.75E-11	Diastolic blood pressure	
SARC	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.62	-6.87	5.6E-11	Diastolic blood pressure	
SARC	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-0.6	-6.85	6.56E-11	Diastolic blood pressure	
SARC	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-0.6	-7.05	1.98E-11	Diastolic blood pressure	
SARC	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-0.6	-7.05	1.98E-11	Diastolic blood pressure	
SARC	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.6	-6.94	3.88E-11	Diastolic blood pressure	
SARC	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.59	6.91	4.55E-11	Diastolic blood pressure	
SARC	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.62	-7.07	1.78E-11	Diastolic blood pressure	
SARC	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.6	-6.95	3.55E-11	Diastolic blood pressure	
SARC	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.6	6.85	6.56E-11	Diastolic blood pressure	
SARC	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.6	6.9	4.88E-11	Diastolic blood pressure	
SARC	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.59	6.8	8.57E-11	Diastolic blood pressure	
SARC	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-0.61	-7.04	2.1E-11	Diastolic blood pressure	
SARC	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-0.59	-6.86	6.05E-11	Diastolic blood pressure	
SARC	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-0.58	-6.84	6.68E-11	Diastolic blood pressure	
SARC	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.61	7.09	1.56E-11	Diastolic blood pressure	
SARC	cis	1	rs1727052	chr6:152947175	FBXO5	chr6:153291660-153304740:-	0.2	4.23	3.35E-5	Tonometry	
SARC	cis	1	rs1727054	chr6:152947742	FBXO5	chr6:153291660-153304740:-	0.19	4.14	4.9E-5	Tonometry	
SARC	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.71	-6.65	2.01E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs17410452	chr10:45170255	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs17411047	chr10:45201663	ALOX5	chr10:45869629-45941561:+	0.21	4.23	3.38E-5	Parkinson's disease	
SARC	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.78	14.67	5.39E-35	Carotid intima media thickness	
SARC	cis	1	rs1744369	chr6:152946531	FBXO5	chr6:153291660-153304740:-	0.2	4.23	3.35E-5	Tonometry	
SARC	cis	1	rs1744379	chr6:152942844	FBXO5	chr6:153291660-153304740:-	0.2	4.12	5.23E-5	Tonometry	
SARC	cis	1	rs17501987	chr10:45194041	ALOX5	chr10:45869629-45941561:+	0.2	4.14	4.88E-5	Parkinson's disease	
SARC	cis	1	rs17502384	chr10:45210241	ALOX5	chr10:45869629-45941561:+	0.2	4.1	5.76E-5	Parkinson's disease	
SARC	cis	1	rs17508283	chr5:88687514	MEF2C	chr5:88014058-88199869:-	0.57	4.22	3.44E-5	Schizophrenia	
SARC	cis	1	rs17538840	chr2:61077817	C2orf74	chr2:61372243-61391964:+	-0.48	-6.23	2.11E-9	Inflammatory skin disease	
SARC	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.41	-4.65	5.58E-6	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.43	4.71	4.23E-6	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.48	-5.38	1.81E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.48	-5.38	1.81E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.47	-5.35	2.12E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.48	-5.38	1.81E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.38	-5.15	5.59E-7	Forced vital capacity	
SARC	cis	1	rs17598927	chr6:26184640	HIST1H3E	chr6:26224427-26226589:+	-0.6	-5.36	1.96E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.75	6.77	1.01E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.53	-9.02	7.18E-17	Temperament	
SARC	cis	1	rs17645523	chr15:50882645	SPPL2A	chr15:50999739-51057910:-	0.25	4.1	5.66E-5	QT interval	
SARC	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.61	-6.78	9.58E-11	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs17671194	chr15:40667539	C15orf23	chr15:40674922-40686488:+	0.39	4.74	3.71E-6	Heschl's gyrus morphology	
SARC	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.3	4.12	5.28E-5	Height	
SARC	cis	1	rs17694011	chr3:134213981	CEP63	chr3:134204575-134293852:+	0.36	5.33	2.36E-7	Height	
SARC	cis	1	rs17713119	chr16:77336426	WWOX	chr16:78133551-79246563:+	-0.37	-4.27	2.87E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	
SARC	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.6	9.23	1.67E-17	Esophageal cancer (squamous cell)	
SARC	cis	1	rs1794693	chr6:167405670	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.24E-5	Crohn's disease	
SARC	cis	1	rs180515	chr17:58024275	DHX40P1	chr17:58053385-58096336:-	0.29	4.22	3.47E-5	Multiple sclerosis	
SARC	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.33	4.35	2.03E-5	Height	
SARC	cis	1	rs1814336	chr3:134200823	CEP63	chr3:134204575-134293852:+	0.36	5.05	9.08E-7	Height	
SARC	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.32	4.35	2.06E-5	Height	
SARC	cis	1	rs1814337	chr3:134200682	CEP63	chr3:134204575-134293852:+	0.36	5.18	4.75E-7	Height	
SARC	cis	1	rs1819333	chr6:167373547	RNASET2	chr6:167343008-167412795:-	-0.18	-4.1	5.73E-5	Crohn's disease	
SARC	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.45	-6.58	2.98E-10	IgG glycosylation	
SARC	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.66	7.43	1.98E-12	Type 2 diabetes	
SARC	cis	1	rs1839622	chr12:7334534	PEX5	chr12:7341759-7371167:+	0.26	4.31	2.36E-5	IgG glycosylation	
SARC	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.48	-5.45	1.28E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs1855647	chr1:72061816	NEGR1	chr1:71868626-72748405:-	0.33	4.13	5.04E-5	Hemostatic factors and hematological phenotypes	
SARC	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.53	-8.65	8.34E-16	Response to antipsychotic treatment	
SARC	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.51	-8.41	4.15E-15	Response to antipsychotic treatment	
SARC	cis	1	rs1859690	chr7:99227172	CYP3A5	chr7:99245818-99332821:-	0.57	5.14	5.75E-7	Blood metabolite levels	
SARC	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.66	7.43	1.98E-12	Type 2 diabetes	
SARC	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.31	4.21	3.59E-5	Height	
SARC	cis	1	rs1863913	chr3:134200205	CEP63	chr3:134204575-134293852:+	0.35	5.1	7.04E-7	Height	
SARC	cis	1	rs1864367	chr3:53111704	RFT1	chr3:53122503-53164470:-	-0.3	-4.55	8.49E-6	Height	
SARC	cis	1	rs1867146	chr15:75354971	SCAMP5	chr15:75287901-75313836:+	0.37	4.46	1.29E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.31	4.05	6.83E-5	Height	
SARC	cis	1	rs1874883	chr3:134205071	CEP63	chr3:134204575-134293852:+	0.36	5.19	4.61E-7	Height	
SARC	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.27	4.18	4.08E-5	Multiple sclerosis	
SARC	cis	1	rs1880376	chr3:134270347	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs1880377	chr3:134270468	CEP63	chr3:134204575-134293852:+	-0.34	-4.84	2.33E-6	Height	
SARC	cis	1	rs1881245	chr2:73649928	ALMS1P	chr2:73872046-73912692:+	0.42	5.37	1.93E-7	Metabolite levels	
SARC	cis	1	rs1882099	chr4:1352685	CRIPAK	chr4:1385340-1389782:+	0.37	4.65	5.59E-6	Systolic blood pressure	
SARC	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.56	-7.94	8.32E-14	Esophageal cancer (squamous cell)	
SARC	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.69	7.57	8.74E-13	Type 2 diabetes	
SARC	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.53	-8.91	1.47E-16	Response to antipsychotic treatment	
SARC	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.51	-8.41	4.15E-15	Response to antipsychotic treatment	
SARC	cis	1	rs1917130	chr3:134313773	CEP63	chr3:134204575-134293852:+	-0.34	-4.88	2.0E-6	Height	
SARC	cis	1	rs1930961	chr22:25875265	CRYBB2	chr22:25615612-25627836:+	0.79	7.59	7.5E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs1947860	chr10:45173921	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.43	-5.35	2.05E-7	Rheumatoid arthritis	
SARC	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.53	-9.26	1.32E-17	Response to antipsychotic treatment	
SARC	cis	1	rs1966423	chr2:202216661	CASP8	chr2:202098166-202152434:+	0.27	4.32	2.27E-5	Basal cell carcinoma	
SARC	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.86	-8.42	3.73E-15	Schizophrenia	
SARC	cis	1	rs1994003	chr10:45176945	ALOX5	chr10:45869629-45941561:+	0.19	4.2	3.82E-5	Parkinson's disease	
SARC	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.58	5.87	1.46E-8	Diastolic blood pressure	
SARC	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.51	-8.41	4.15E-15	Response to antipsychotic treatment	
SARC	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.54	-9.18	2.37E-17	Response to antipsychotic treatment	
SARC	cis	1	rs2004711	chr5:150225068	IRGM	chr5:150226085-150280295:+	0.49	4.47	1.23E-5	Crohn's disease	
SARC	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.38	-4.9	1.77E-6	Forced vital capacity	
SARC	cis	1	rs2013815	chr6:167373812	RNASET2	chr6:167343008-167412795:-	0.17	4.05	7.03E-5	Crohn's disease	
SARC	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.6	-7.39	2.61E-12	Type 2 diabetes	
SARC	cis	1	rs204246	chr6:13723374	CCDC90A	chr6:13791021-13814789:-	0.29	4.57	7.95E-6	Breast cancer	
SARC	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.23	4.66	5.28E-6	Longevity	
SARC	cis	1	rs2056486	chr2:73717567	ALMS1P	chr2:73872046-73912692:+	0.44	5.44	1.35E-7	Metabolite levels	
SARC	cis	1	rs2056544	chr15:76826003	SCAPER	chr15:76640529-77197744:-	-0.21	-4.87	2.07E-6	Blood metabolite levels	
SARC	cis	1	rs2056603	chr3:134312749	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.45E-6	Height	
SARC	cis	1	rs2056604	chr3:134312648	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.45E-6	Height	
SARC	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.4	-4.63	6.01E-6	Subcutaneous adipose tissue	
SARC	cis	1	rs2069045	chr10:45228636	ALOX5	chr10:45869629-45941561:+	0.21	4.24	3.2E-5	Parkinson's disease	
SARC	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.28	-4.27	2.87E-5	Multiple sclerosis	
SARC	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.26	4.15	4.66E-5	Multiple sclerosis	
SARC	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.37	7.39	2.58E-12	Common traits (Other)	
SARC	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.56	-8.58	1.36E-15	Homocysteine levels	
SARC	cis	1	rs2080303	chr2:202165206	CASP8	chr2:202098166-202152434:+	0.32	4.54	9.1E-6	Basal cell carcinoma	
SARC	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.49	-5.51	9.59E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.36	4.48	1.15E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs2086420	chr10:45172784	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs2101070	chr10:45172697	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs2101071	chr10:45172695	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.7	7.88	1.2E-13	Type 2 diabetes	
SARC	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.56	6.19	2.7E-9	Diastolic blood pressure	
SARC	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.58	6.52	4.35E-10	Diastolic blood pressure	
SARC	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.4	-8.55	1.64E-15	Kawasaki disease	
SARC	cis	1	rs2135829	chr12:51814395	LOC283404	chr12:52604714-52617595:+	0.61	4.14	4.92E-5	White matter lesion progression;White matter lesion progression (adjusted for white matter lesion burden at baseline)	
SARC	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.43	5.27	3.14E-7	Metabolite levels	
SARC	cis	1	rs2143062	chr6:27353852	ZNF391	chr6:27356524-27369227:+	0.31	4.66	5.32E-6	Glomerular filtration rate (creatinine)	
SARC	cis	1	rs2143346	chr6:26198449	HIST1H3E	chr6:26224427-26226589:+	-0.59	-5.63	5.05E-8	Renal underexcretion gout;Gout	
SARC	cis	1	rs2143347	chr6:26198494	HIST1H3E	chr6:26224427-26226589:+	0.58	5.5	1.01E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs2149085	chr6:167371110	RNASET2	chr6:167343008-167412795:-	0.17	4.05	6.98E-5	Crohn's disease	
SARC	cis	1	rs2149090	chr6:167372764	RNASET2	chr6:167343008-167412795:-	0.17	4.05	6.99E-5	Crohn's disease	
SARC	cis	1	rs2149091	chr6:167372786	RNASET2	chr6:167343008-167412795:-	0.17	4.05	6.99E-5	Crohn's disease	
SARC	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.38	-4.99	1.2E-6	Eye color traits	
SARC	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.53	-9.02	7.17E-17	Response to antipsychotic treatment	
SARC	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.43	6	7.35E-9	Body mass index	
SARC	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.4	-5.6	6.03E-8	Body mass index	
SARC	cis	1	rs2177601	chr3:134245434	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs2184232	chr1:72046723	NEGR1	chr1:71868626-72748405:-	-0.35	-4.23	3.41E-5	Hemostatic factors and hematological phenotypes	
SARC	cis	1	rs2187143	chr18:48371565	MRO	chr18:48321491-48351754:-	0.4	4.28	2.69E-5	Entorhinal cortical thickness	
SARC	cis	1	rs2198042	chr4:129885499	C4orf33	chr4:130014829-130033842:+	0.51	5.73	3.14E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.3	7.08	1.62E-11	Type 1 diabetes autoantibodies	
SARC	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.47	-8.49	2.35E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.47	9.16	2.69E-17	Homocysteine levels	
SARC	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.37	7.29	4.68E-12	Common traits (Other)	
SARC	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.23	4.67	5.07E-6	Longevity	
SARC	cis	1	rs224329	chr20:34019579	CPNE1	chr20:34213968-34262539:-	-0.3	-4.17	4.27E-5	Height	
SARC	cis	1	rs2248393	chr20:33926103	CPNE1	chr20:34213968-34262539:-	-0.32	-4.36	1.94E-5	Height	
SARC	cis	1	rs2250006	chr6:153006401	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs2250514	chr6:153010920	FBXO5	chr6:153291660-153304740:-	-0.2	-4.29	2.63E-5	Tonometry	
SARC	cis	1	rs2250632	chr6:153011126	FBXO5	chr6:153291660-153304740:-	-0.21	-4.5	1.05E-5	Tonometry	
SARC	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.43	-8.2	1.64E-14	Homocysteine levels	
SARC	cis	1	rs2253209	chr3:53115160	RFT1	chr3:53122503-53164470:-	-0.28	-4.31	2.45E-5	Height	
SARC	cis	1	rs2253656	chr3:53119099	RFT1	chr3:53122503-53164470:-	-0.28	-4.31	2.37E-5	Height	
SARC	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-0.61	-7	2.76E-11	Diastolic blood pressure	
SARC	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.62	-7.19	8.6E-12	Diastolic blood pressure	
SARC	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.3	6.72	1.4E-10	Longevity	
SARC	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.17	4.22E-5	Body mass index	
SARC	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.41	-5.81	2.07E-8	Body mass index	
SARC	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.55	-6.33	1.22E-9	Cholesterol, total	
SARC	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.26	-5.58	6.65E-8	Longevity	
SARC	cis	1	rs2289329	chr15:40705159	DISP2	chr15:40650434-40663256:+	0.32	4.59	7.25E-6	Blood metabolite levels;Blood metabolite ratios	
SARC	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.25	-5.2	4.43E-7	Longevity	
SARC	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.55	8.78	3.47E-16	Cognitive function	
SARC	cis	1	rs2301889	chr7:98931105	CYP3A5	chr7:99245818-99332821:-	0.63	5.48	1.09E-7	Blood metabolite levels	
SARC	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.43	-6.37	9.88E-10	Multiple sclerosis	
SARC	cis	1	rs2312462	chr3:49601255	AMT	chr3:49454212-49460012:-	0.23	4.11	5.48E-5	Menarche (age at onset)	
SARC	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.54	-8.73	4.97E-16	Response to antipsychotic treatment	
SARC	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.6	-7.32	3.84E-12	Type 2 diabetes	
SARC	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.6	-7.32	3.84E-12	Type 2 diabetes	
SARC	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.55	-8.4	4.44E-15	Homocysteine levels	
SARC	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.54	-8.29	8.68E-15	Homocysteine levels	
SARC	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.37	-7.08	1.68E-11	Common traits (Other)	
SARC	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.37	-7.38	2.78E-12	Common traits (Other)	
SARC	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.22	-4.65	5.52E-6	Longevity	
SARC	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.21	4.4	1.66E-5	Longevity	
SARC	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.33	4.35	2.0E-5	Height	
SARC	cis	1	rs2370578	chr3:134199612	CEP63	chr3:134204575-134293852:+	0.36	5.06	8.34E-7	Height	
SARC	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.3	4.08	6.06E-5	Height	
SARC	cis	1	rs2370641	chr3:134222161	CEP63	chr3:134204575-134293852:+	0.36	5.23	3.71E-7	Height	
SARC	cis	1	rs2370642	chr3:134222136	CEP63	chr3:134204575-134293852:+	0.35	5.04	9.33E-7	Height	
SARC	cis	1	rs2371623	chr3:41761083	ULK4	chr3:41288091-42003660:-	0.6	6.84	6.76E-11	Diastolic blood pressure	
SARC	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	0.61	7	2.68E-11	Diastolic blood pressure	
SARC	cis	1	rs2373865	chr3:134291556	CEP63	chr3:134204575-134293852:+	-0.34	-4.84	2.34E-6	Height	
SARC	cis	1	rs2404602	chr15:77030792	SCAPER	chr15:76640529-77197744:-	-0.2	-4.52	9.97E-6	Blood metabolite levels	
SARC	cis	1	rs2404740	chr15:76852143	SCAPER	chr15:76640529-77197744:-	-0.2	-4.59	7.18E-6	Blood metabolite levels	
SARC	cis	1	rs2404741	chr15:76851735	SCAPER	chr15:76640529-77197744:-	-0.2	-4.59	7.18E-6	Blood metabolite levels	
SARC	cis	1	rs2415253	chr15:75375699	SCAMP5	chr15:75287901-75313836:+	0.34	4.39	1.74E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs2421555	chr2:73816955	ALMS1P	chr2:73872046-73912692:+	0.47	5.81	2.01E-8	Metabolite levels	
SARC	cis	1	rs2425065	chr20:33926268	CPNE1	chr20:34213968-34262539:-	-0.32	-4.48	1.15E-5	Height	
SARC	cis	1	rs2425066	chr20:33927006	CPNE1	chr20:34213968-34262539:-	-0.32	-4.48	1.15E-5	Height	
SARC	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.69	7.73	3.13E-13	Type 2 diabetes	
SARC	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.45	8.54	1.68E-15	Homocysteine levels	
SARC	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.26	4.62	6.4E-6	Folate pathway vitamin levels	
SARC	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.46	-6.9	4.82E-11	Ankylosing spondylitis	
SARC	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.43	5.35	2.1E-7	Ankylosing spondylitis	
SARC	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.26	4.53	9.6E-6	Folate pathway vitamin levels	
SARC	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.26	4.51	1.04E-5	Folate pathway vitamin levels	
SARC	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.48	7.35	3.27E-12	Bipolar disorder and schizophrenia	
SARC	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.67	7.4	2.36E-12	Type 2 diabetes	
SARC	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.67	7.36	3.02E-12	Type 2 diabetes	
SARC	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.69	7.51	1.25E-12	Type 2 diabetes	
SARC	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.7	7.63	5.79E-13	Type 2 diabetes	
SARC	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.68	7.44	1.96E-12	Type 2 diabetes	
SARC	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.68	-7.4	2.5E-12	Type 2 diabetes	
SARC	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.69	7.73	3.13E-13	Type 2 diabetes	
SARC	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.7	7.63	5.79E-13	Type 2 diabetes	
SARC	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.69	7.69	4.1E-13	Type 2 diabetes	
SARC	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.7	7.83	1.68E-13	Type 2 diabetes	
SARC	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.71	7.8	2.03E-13	Type 2 diabetes	
SARC	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.71	7.8	2.03E-13	Type 2 diabetes	
SARC	cis	1	rs2564921	chr3:53125585	RFT1	chr3:53122503-53164470:-	0.28	4.34	2.08E-5	Height	
SARC	cis	1	rs2564940	chr3:53107569	RFT1	chr3:53122503-53164470:-	-0.29	-4.34	2.1E-5	Height	
SARC	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.26	-4.04	7.34E-5	Height	
SARC	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.26	-4.04	7.34E-5	Height	
SARC	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.27	-4.2	3.81E-5	Height	
SARC	cis	1	rs2581787	chr3:53127677	RFT1	chr3:53122503-53164470:-	-0.27	-4.22	3.5E-5	Height	
SARC	cis	1	rs2581800	chr3:53109352	RFT1	chr3:53122503-53164470:-	-0.28	-4.18	4.09E-5	Height	
SARC	cis	1	rs2610739	chr6:89253649	ORC3L	chr6:88299843-88377166:+	-0.49	-4.89	1.85E-6	IgG glycosylation	
SARC	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.45	-6.89	4.97E-11	Ankylosing spondylitis	
SARC	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.45	5.63	5.26E-8	Ankylosing spondylitis	
SARC	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.49	-5.48	1.12E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.61	7.09	1.56E-11	Diastolic blood pressure	
SARC	cis	1	rs2683696	chr3:41914898	ULK4	chr3:41288091-42003660:-	0.62	7.09	1.59E-11	Diastolic blood pressure	
SARC	cis	1	rs2702040	chr2:24541561	NCOA1	chr2:24787179-24993568:+	0.42	4.98	1.23E-6	Response to antipsychotic treatment in schizophrenia (working memory)	
SARC	cis	1	rs2702040	chr2:24541561	SF3B14	chr2:24290455-24299314:-	0.52	4.86	2.13E-6	Response to antipsychotic treatment in schizophrenia (working memory)	
SARC	cis	1	rs2703075	chr13:50835968	DLEU1	chr13:50656414-51102670:+	0.39	4.29	2.66E-5	Celiac disease	
SARC	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.45	-6.8	8.83E-11	Ankylosing spondylitis	
SARC	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.46	5.73	3.08E-8	Ankylosing spondylitis	
SARC	cis	1	rs2757047	chr6:167374489	RNASET2	chr6:167343008-167412795:-	0.17	4.05	7.03E-5	Crohn's disease	
SARC	cis	1	rs2758776	chr6:153006317	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs2758777	chr6:153007467	FBXO5	chr6:153291660-153304740:-	-0.22	-4.66	5.26E-6	Tonometry	
SARC	cis	1	rs2758779	chr6:153008022	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs2758780	chr6:153008108	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs2758782	chr6:153010341	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs2758784	chr6:153010489	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs2758785	chr6:153010878	FBXO5	chr6:153291660-153304740:-	-0.21	-4.52	9.73E-6	Tonometry	
SARC	cis	1	rs2758816	chr6:152968338	FBXO5	chr6:153291660-153304740:-	0.2	4.11	5.42E-5	Tonometry	
SARC	cis	1	rs2769347	chr6:167371737	RNASET2	chr6:167343008-167412795:-	0.17	4.05	6.98E-5	Crohn's disease	
SARC	cis	1	rs2769354	chr6:167379771	RNASET2	chr6:167343008-167412795:-	0.17	4.05	7.03E-5	Crohn's disease	
SARC	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.43	6.51	4.43E-10	Ankylosing spondylitis	
SARC	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.44	-5.6	6.0E-8	Ankylosing spondylitis	
SARC	cis	1	rs2800623	chr6:153003720	FBXO5	chr6:153291660-153304740:-	-0.21	-4.37	1.88E-5	Tonometry	
SARC	cis	1	rs2800625	chr6:153006016	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs2800626	chr6:153006340	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs2800630	chr6:153008261	FBXO5	chr6:153291660-153304740:-	-0.21	-4.56	8.26E-6	Tonometry	
SARC	cis	1	rs2800631	chr6:153008631	FBXO5	chr6:153291660-153304740:-	-0.21	-4.6	6.99E-6	Tonometry	
SARC	cis	1	rs2800632	chr6:153008632	FBXO5	chr6:153291660-153304740:-	-0.21	-4.6	6.99E-6	Tonometry	
SARC	cis	1	rs2800633	chr6:153010308	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs2800634	chr6:153010414	FBXO5	chr6:153291660-153304740:-	-0.2	-4.22	3.52E-5	Tonometry	
SARC	cis	1	rs2800637	chr6:153034155	FBXO5	chr6:153291660-153304740:-	-0.22	-4.59	7.38E-6	Tonometry	
SARC	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.51	-5.81	2.05E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.5	-5.69	3.75E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.54	-9.27	1.26E-17	Response to antipsychotic treatment	
SARC	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.53	-9.33	8.51E-18	Response to antipsychotic treatment	
SARC	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.52	-8.7	5.93E-16	Response to antipsychotic treatment	
SARC	cis	1	rs2833888	chr21:33927560	TCP10L	chr21:33947152-33957845:-	-0.42	-4.26	3.01E-5	Gastritis	
SARC	cis	1	rs2833889	chr21:33927768	TCP10L	chr21:33947152-33957845:-	0.41	4.24	3.18E-5	Gastritis	
SARC	cis	1	rs2833890	chr21:33927886	TCP10L	chr21:33947152-33957845:-	0.4	4.11	5.41E-5	Gastritis	
SARC	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.38	-5	1.14E-6	Eye color traits	
SARC	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.38	-4.99	1.2E-6	Eye color traits	
SARC	cis	1	rs2838009	chr21:42694284	FAM3B	chr21:42676177-42729654:+	-0.43	-4.93	1.58E-6	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
SARC	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.27	-4.52	9.7E-6	Testicular germ cell tumor	
SARC	cis	1	rs28409322	chr3:134252385	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs28468623	chr7:98922812	CYP3A5	chr7:99245818-99332821:-	0.61	5.39	1.73E-7	Blood metabolite levels	
SARC	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.38	-4.19	3.99E-5	Glycated hemoglobin levels	
SARC	cis	1	rs2849246	chr18:48371896	MRO	chr18:48321491-48351754:-	-0.4	-4.15	4.61E-5	Entorhinal cortical thickness	
SARC	cis	1	rs28540190	chr19:49135043	SEC1	chr19:49141296-49185501:+	-0.57	-5	1.13E-6	Elevated serum carcinoembryonic antigen levels	
SARC	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.39	5.05	8.92E-7	Forced vital capacity	
SARC	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.36	4.65	5.6E-6	Forced vital capacity	
SARC	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.38	-4.94	1.48E-6	Forced vital capacity	
SARC	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.58	5.87	1.46E-8	Diastolic blood pressure	
SARC	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.58	6.52	4.35E-10	Diastolic blood pressure	
SARC	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.56	5.61	5.73E-8	Diastolic blood pressure	
SARC	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.25	5.32	2.45E-7	Longevity	
SARC	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.33	4.35	2.03E-5	Height	
SARC	cis	1	rs2887797	chr3:134202506	CEP63	chr3:134204575-134293852:+	0.36	5.05	9.08E-7	Height	
SARC	cis	1	rs2896954	chr15:76851692	SCAPER	chr15:76640529-77197744:-	-0.21	-4.66	5.2E-6	Blood metabolite levels	
SARC	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.45	5.59	6.23E-8	Metabolite levels	
SARC	cis	1	rs2935183	chr17:45607572	C17orf57	chr17:45401142-45518675:+	-0.31	-4.93	1.55E-6	Multiple sclerosis or amyotrophic lateral sclerosis	
SARC	cis	1	rs2969775	chr2:47885476	GTF2A1L	chr2:48844948-48960284:+	-0.31	-4.36	1.91E-5	Psychosis in Alzheimer's disease	
SARC	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.26	4.5	1.05E-5	Schizophrenia	
SARC	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.54	-8.37	5.41E-15	Homocysteine levels	
SARC	cis	1	rs2996635	chr6:153011163	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.45	-6.87	5.63E-11	Ankylosing spondylitis	
SARC	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.45	5.6	6.05E-8	Ankylosing spondylitis	
SARC	cis	1	rs302660	chr11:87885448	RAB38	chr11:87846431-87908599:-	0.28	4.11	5.49E-5	Frontotemporal dementia	
SARC	cis	1	rs302662	chr11:87881236	RAB38	chr11:87846431-87908599:-	0.29	4.24	3.21E-5	Frontotemporal dementia	
SARC	cis	1	rs302663	chr11:87880759	RAB38	chr11:87846431-87908599:-	0.29	4.15	4.65E-5	Frontotemporal dementia	
SARC	cis	1	rs302668	chr11:87876911	RAB38	chr11:87846431-87908599:-	0.28	4.08	6.15E-5	Frontotemporal dementia	
SARC	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.46	-7.01	2.52E-11	Ankylosing spondylitis	
SARC	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.43	5.39	1.71E-7	Ankylosing spondylitis	
SARC	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.46	-7.04	2.17E-11	Ankylosing spondylitis	
SARC	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.44	5.44	1.37E-7	Ankylosing spondylitis	
SARC	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.46	-7.04	2.17E-11	Ankylosing spondylitis	
SARC	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.44	5.44	1.37E-7	Ankylosing spondylitis	
SARC	cis	1	rs3091242	chr1:25674785	RHCE	chr1:25688741-25756683:-	0.36	4.89	1.91E-6	Erythrocyte sedimentation rate	
SARC	cis	1	rs3091242	chr1:25674785	RHD	chr1:25598981-25656935:+	-0.41	-5.31	2.61E-7	Erythrocyte sedimentation rate	
SARC	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.7	7.74	3.05E-13	Type 2 diabetes	
SARC	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.5	-5.69	3.75E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.48	-5.38	1.81E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs3109895	chr15:50880560	SPPL2A	chr15:50999739-51057910:-	0.25	4.1	5.66E-5	QT interval	
SARC	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.49	-5.51	9.35E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.55	-5.37	1.9E-7	Dental caries	
SARC	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.49	-9.15	2.97E-17	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.26	-5.62	5.4E-8	Longevity	
SARC	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.31	4.09	5.92E-5	Renal underexcretion gout;Gout	
SARC	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.69	7.69	4.1E-13	Type 2 diabetes	
SARC	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs34087092	chr8:126504762	NDUFB9	chr8:125551343-125580751:+	-0.25	-4.17	4.37E-5	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
SARC	cis	1	rs34087092	chr8:126504762	TATDN1	chr8:125500735-125551329:-	-0.28	-4.03	7.57E-5	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
SARC	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.31	2.44E-5	Body mass index	
SARC	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.53	-9.08	4.59E-17	Response to antipsychotic treatment	
SARC	cis	1	rs34156253	chr5:150226230	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.35	4.28	2.75E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.55	-9.35	7.54E-18	Response to antipsychotic treatment	
SARC	cis	1	rs34333482	chr6:116855952	FAM26F	chr6:116782556-116784933:+	0.17	4.25	3.1E-5	Pelvic organ prolapse (moderate/severe)	
SARC	cis	1	rs34344888	chr14:23387585	HAUS4	chr14:23415438-23426335:-	-0.38	-4.8	2.83E-6	Educational attainment (years of education)	
SARC	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.41	5.73	3.08E-8	Body mass index	
SARC	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.54	-9.02	6.98E-17	Response to antipsychotic treatment	
SARC	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.51	-8.41	4.15E-15	Response to antipsychotic treatment	
SARC	cis	1	rs34660870	chr10:45168082	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.36	-4.11	5.52E-5	Menarche (age at onset)	
SARC	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.39	4.07	6.47E-5	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.53	-9.09	4.44E-17	Response to antipsychotic treatment	
SARC	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.51	5.83	1.84E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.4	-5.16	5.34E-7	Forced vital capacity	
SARC	cis	1	rs35193371	chr20:48126879	STAU1	chr20:47729878-47805288:-	-0.31	-4.16	4.52E-5	Schizophrenia	
SARC	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.53	-8.91	1.47E-16	Response to antipsychotic treatment	
SARC	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.55	-9.35	7.54E-18	Response to antipsychotic treatment	
SARC	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.56	8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs35577967	chr15:75354621	SCAMP5	chr15:75287901-75313836:+	0.37	4.46	1.29E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs35718987	chr3:134272783	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.53	-8.91	1.47E-16	Response to antipsychotic treatment	
SARC	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.53	-8.48	2.49E-15	Response to antipsychotic treatment	
SARC	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.53	-8.86	2.11E-16	Response to antipsychotic treatment	
SARC	cis	1	rs35835884	chr10:127708468	UROS	chr10:127477148-127511837:-	-0.29	-5.2	4.29E-7	Visceral fat	
SARC	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.53	-9.09	4.44E-17	Response to antipsychotic treatment	
SARC	cis	1	rs364283	chr6:167383750	RNASET2	chr6:167343008-167412795:-	-0.17	-4.05	7.06E-5	Crohn's disease	
SARC	cis	1	rs365189	chr6:167384545	RNASET2	chr6:167343008-167412795:-	-0.17	-4.05	7.03E-5	Crohn's disease	
SARC	cis	1	rs368512	chr6:13718126	CCDC90A	chr6:13791021-13814789:-	0.27	4.29	2.57E-5	Breast cancer	
SARC	cis	1	rs371674	chr21:42695445	FAM3B	chr21:42676177-42729654:+	0.43	4.91	1.68E-6	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
SARC	cis	1	rs371729	chr6:13719129	CCDC90A	chr6:13791021-13814789:-	0.27	4.25	3.13E-5	Breast cancer	
SARC	cis	1	rs3734530	chr6:26195408	HIST1H3E	chr6:26224427-26226589:+	0.58	5.46	1.23E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs3739821	chr9:130702477	PIP5KL1	chr9:130683809-130693076:-	-0.51	-5.9	1.29E-8	Glaucoma (primary angle closure)	
SARC	cis	1	rs3745734	chr19:49134388	SEC1	chr19:49141296-49185501:+	-0.57	-5	1.13E-6	Elevated serum carcinoembryonic antigen levels	
SARC	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.43	8.35	6.18E-15	Schizophrenia	
SARC	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.38	4.08	6.26E-5	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.33	6.42	7.42E-10	Fractional exhaled nitric oxide (childhood)	
SARC	cis	1	rs3757135	chr6:26200707	HIST1H3E	chr6:26224427-26226589:+	0.59	5.52	8.89E-8	Renal underexcretion gout;Gout	
SARC	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.31	7.12	1.3E-11	Type 1 diabetes autoantibodies	
SARC	cis	1	rs376551	chr6:167384923	RNASET2	chr6:167343008-167412795:-	-0.17	-4.04	7.11E-5	Crohn's disease	
SARC	cis	1	rs376574	chr6:167389956	RNASET2	chr6:167343008-167412795:-	-0.17	-4.09	5.84E-5	Crohn's disease	
SARC	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.5	5.21	4.16E-7	Diastolic blood pressure	
SARC	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.26	-5.58	6.65E-8	Longevity	
SARC	cis	1	rs3781001	chr10:127706028	UROS	chr10:127477148-127511837:-	-0.3	-5.19	4.47E-7	Visceral fat	
SARC	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.28	4.39	1.72E-5	Multiple sclerosis	
SARC	cis	1	rs379161	chr6:13717387	CCDC90A	chr6:13791021-13814789:-	0.27	4.26	2.99E-5	Breast cancer	
SARC	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.36	-7.15	1.13E-11	Kawasaki disease	
SARC	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.33	-5.24	3.62E-7	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.44	-5.5	9.88E-8	Metabolite levels	
SARC	cis	1	rs381551	chr6:13716723	CCDC90A	chr6:13791021-13814789:-	-0.31	-4.72	4.12E-6	Breast cancer	
SARC	cis	1	rs3816804	chr12:56680745	RPS26	chr12:56435686-56438005:+	0.48	4.49	1.14E-5	Height	
SARC	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.25	-4.45	1.3E-5	Folate pathway vitamin levels	
SARC	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.27	4.19	4.03E-5	Multiple sclerosis	
SARC	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.45	8.19	1.69E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.41	-4.17	4.32E-5	Abdominal aortic aneurysm	
SARC	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.33	4.35	2.03E-5	Height	
SARC	cis	1	rs3846055	chr3:134203973	CEP63	chr3:134204575-134293852:+	0.36	5.05	9.08E-7	Height	
SARC	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.3	4.12	5.2E-5	Height	
SARC	cis	1	rs3846056	chr3:134227292	CEP63	chr3:134204575-134293852:+	0.36	5.34	2.19E-7	Height	
SARC	cis	1	rs385113	chr6:167403971	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.23E-5	Crohn's disease	
SARC	cis	1	rs385863	chr6:167386615	RNASET2	chr6:167343008-167412795:-	-0.17	-4.09	5.84E-5	Crohn's disease	
SARC	cis	1	rs386548	chr6:167385533	RNASET2	chr6:167343008-167412795:-	0.17	4.09	5.93E-5	Crohn's disease	
SARC	cis	1	rs3890604	chr3:41760625	ULK4	chr3:41288091-42003660:-	0.62	7.01	2.55E-11	Diastolic blood pressure	
SARC	cis	1	rs389946	chr6:167407268	RNASET2	chr6:167343008-167412795:-	-0.18	-4.18	4.2E-5	Crohn's disease	
SARC	cis	1	rs389956	chr6:167407254	RNASET2	chr6:167343008-167412795:-	-0.17	-4.12	5.33E-5	Crohn's disease	
SARC	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.52	-5.88	1.39E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.3	4.13	4.97E-5	Height	
SARC	cis	1	rs3932818	chr3:134206069	CEP63	chr3:134204575-134293852:+	0.36	5.28	2.88E-7	Height	
SARC	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.62	-6.84	7.03E-11	Diastolic blood pressure	
SARC	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.56	8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs393558	chr6:167397750	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.23E-5	Crohn's disease	
SARC	cis	1	rs393727	chr6:167398632	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.23E-5	Crohn's disease	
SARC	cis	1	rs394522	chr6:167398071	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.23E-5	Crohn's disease	
SARC	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.6	-7.32	3.84E-12	Type 2 diabetes	
SARC	cis	1	rs397713	chr6:167386714	RNASET2	chr6:167343008-167412795:-	-0.17	-4.09	5.84E-5	Crohn's disease	
SARC	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.48	-6.74	1.2E-10	Inflammatory skin disease	
SARC	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.45	5.14	5.76E-7	Inflammatory skin disease	
SARC	cis	1	rs400063	chr6:167386592	RNASET2	chr6:167343008-167412795:-	-0.17	-4.11	5.37E-5	Crohn's disease	
SARC	cis	1	rs400176	chr6:167406238	RNASET2	chr6:167343008-167412795:-	-0.17	-4.11	5.46E-5	Crohn's disease	
SARC	cis	1	rs402749	chr6:167386104	RNASET2	chr6:167343008-167412795:-	-0.17	-4.09	5.84E-5	Crohn's disease	
SARC	cis	1	rs404222	chr6:167402150	RNASET2	chr6:167343008-167412795:-	-0.17	-4.04	7.17E-5	Crohn's disease	
SARC	cis	1	rs405447	chr6:13713099	CCDC90A	chr6:13791021-13814789:-	0.27	4.22	3.49E-5	Breast cancer	
SARC	cis	1	rs405553	chr6:167395058	RNASET2	chr6:167343008-167412795:-	-0.17	-4.09	5.83E-5	Crohn's disease	
SARC	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.55	-8.21	1.49E-14	Eye color traits	
SARC	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.56	-8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.36	1.91E-5	Body mass index	
SARC	cis	1	rs408040	chr6:167398903	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.23E-5	Crohn's disease	
SARC	cis	1	rs408087	chr6:167398952	RNASET2	chr6:167343008-167412795:-	-0.17	-4.12	5.33E-5	Crohn's disease	
SARC	cis	1	rs409356	chr6:167405226	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.24E-5	Crohn's disease	
SARC	cis	1	rs41266807	chr6:26199822	HIST1H3E	chr6:26224427-26226589:+	0.58	5.49	1.02E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs413232	chr6:167400972	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.23E-5	Crohn's disease	
SARC	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.25	3.05E-5	Body mass index	
SARC	cis	1	rs41433250	chr13:31495835	HSPH1	chr13:31710765-31736502:-	0.55	4.93	1.58E-6	Influenza A (H1N1) infection;Mild influenza (H1N1) infection	
SARC	cis	1	rs41433250	chr13:31495835	USPL1	chr13:31191830-31233686:+	0.55	4.8	2.86E-6	Influenza A (H1N1) infection;Mild influenza (H1N1) infection	
SARC	cis	1	rs415842	chr6:167406681	RNASET2	chr6:167343008-167412795:-	-0.17	-4.12	5.33E-5	Crohn's disease	
SARC	cis	1	rs416131	chr6:167406544	RNASET2	chr6:167343008-167412795:-	0.19	4.38	1.77E-5	Crohn's disease	
SARC	cis	1	rs418720	chr6:13718399	CCDC90A	chr6:13791021-13814789:-	0.27	4.29	2.57E-5	Breast cancer	
SARC	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.31	-4.17	4.35E-5	Bipolar disorder	
SARC	cis	1	rs421214	chr6:167396629	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.33E-5	Crohn's disease	
SARC	cis	1	rs422094	chr6:167397033	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.25E-5	Crohn's disease	
SARC	cis	1	rs422694	chr6:167406074	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.24E-5	Crohn's disease	
SARC	cis	1	rs422780	chr6:167406209	RNASET2	chr6:167343008-167412795:-	-0.17	-4.11	5.46E-5	Crohn's disease	
SARC	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.39	5.12	6.46E-7	Forced vital capacity	
SARC	cis	1	rs4253766	chr22:46623905	PKDREJ	chr22:46651561-46659219:-	-0.45	-4.28	2.74E-5	Cholesterol, total;LDL cholesterol	
SARC	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.32	5.65	4.55E-8	Folate pathway vitamin levels	
SARC	cis	1	rs4268462	chr10:45164658	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.27	-6.02	6.59E-9	Longevity	
SARC	cis	1	rs429083	chr6:167383972	RNASET2	chr6:167343008-167412795:-	-0.17	-4.05	7.06E-5	Crohn's disease	
SARC	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.5	6.07	5.15E-9	Paget's disease	
SARC	cis	1	rs430097	chr6:167405073	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.24E-5	Crohn's disease	
SARC	cis	1	rs430293	chr6:167404958	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.24E-5	Crohn's disease	
SARC	cis	1	rs430477	chr6:167389851	RNASET2	chr6:167343008-167412795:-	-0.17	-4.09	5.84E-5	Crohn's disease	
SARC	cis	1	rs4309773	chr3:134277301	CEP63	chr3:134204575-134293852:+	0.34	5	1.12E-6	Height	
SARC	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.43	-5.3	2.74E-7	Rheumatoid arthritis	
SARC	cis	1	rs4334685	chr3:134304335	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.45E-6	Height	
SARC	cis	1	rs433852	chr19:49117104	SEC1	chr19:49141296-49185501:+	-0.49	-6.73	1.3E-10	Elevated serum carcinoembryonic antigen levels;Posterior cortical atrophy and Alzheimer's disease	
SARC	cis	1	rs4356177	chr10:45163568	ALOX5	chr10:45869629-45941561:+	0.2	4.17	4.32E-5	Parkinson's disease	
SARC	cis	1	rs4362097	chr10:45164507	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs4362098	chr10:45164510	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs4363543	chr10:45164928	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs4363544	chr10:45164973	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs436707	chr6:167388843	RNASET2	chr6:167343008-167412795:-	-0.17	-4.09	5.84E-5	Crohn's disease	
SARC	cis	1	rs4367113	chr3:134287975	CEP63	chr3:134204575-134293852:+	0.34	4.93	1.54E-6	Height	
SARC	cis	1	rs4368544	chr3:134300014	CEP63	chr3:134204575-134293852:+	-0.34	-4.88	2.0E-6	Height	
SARC	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.41	-5.7	3.61E-8	Body mass index	
SARC	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.31	4.82	2.59E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs439237	chr6:167391392	RNASET2	chr6:167343008-167412795:-	-0.17	-4.09	5.84E-5	Crohn's disease	
SARC	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.51	5.81	2.05E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs439553	chr6:167391212	RNASET2	chr6:167343008-167412795:-	-0.17	-4.11	5.37E-5	Crohn's disease	
SARC	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.34	4.49	1.12E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
SARC	cis	1	rs4417907	chr3:134291363	CEP63	chr3:134204575-134293852:+	0.34	4.84	2.34E-6	Height	
SARC	cis	1	rs441810	chr21:42698907	FAM3B	chr21:42676177-42729654:+	0.42	4.77	3.2E-6	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
SARC	cis	1	rs4423809	chr3:134300107	CEP63	chr3:134204575-134293852:+	-0.34	-4.88	2.0E-6	Height	
SARC	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.5	-5.67	4.11E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.26	-4.52	9.75E-6	Folate pathway vitamin levels	
SARC	cis	1	rs448060	chr6:167382622	RNASET2	chr6:167343008-167412795:-	-0.17	-4.05	7.03E-5	Crohn's disease	
SARC	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.24	-5.12	6.4E-7	Longevity	
SARC	cis	1	rs449043	chr21:42700410	FAM3B	chr21:42676177-42729654:+	-0.46	-5.21	4.15E-7	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
SARC	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.33	4.35	2.0E-5	Height	
SARC	cis	1	rs4498009	chr3:134198008	CEP63	chr3:134204575-134293852:+	0.36	5.06	8.34E-7	Height	
SARC	cis	1	rs4535272	chr3:134299916	CEP63	chr3:134204575-134293852:+	-0.34	-4.92	1.61E-6	Height	
SARC	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.41	-5.7	3.61E-8	Body mass index	
SARC	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.27	4.2	3.84E-5	Hematology traits	
SARC	cis	1	rs4572812	chr3:134291177	CEP63	chr3:134204575-134293852:+	-0.34	-4.84	2.34E-6	Height	
SARC	cis	1	rs4579248	chr5:150268151	IRGM	chr5:150226085-150280295:+	0.54	4.48	1.16E-5	Crohn's disease	
SARC	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.4	-5.6	6.03E-8	Body mass index	
SARC	cis	1	rs4646457	chr7:99245080	COPS6	chr7:99686583-99689820:+	0.37	4.09	5.92E-5	Blood metabolite levels	
SARC	cis	1	rs4646457	chr7:99245080	CYP3A5	chr7:99245818-99332821:-	0.62	5.8	2.15E-8	Blood metabolite levels	
SARC	cis	1	rs4646457	chr7:99245080	MCM7	chr7:99690404-99699427:-	0.31	4.02	7.76E-5	Blood metabolite levels	
SARC	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.27	4.39	1.69E-5	Multiple sclerosis	
SARC	cis	1	rs4649941	chr1:72031176	NEGR1	chr1:71868626-72748405:-	-0.34	-4.1	5.63E-5	Hemostatic factors and hematological phenotypes	
SARC	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.52	7.92	9.74E-14	Homocysteine levels	
SARC	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.25	-4.04	7.16E-5	Body mass index	
SARC	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.54	-8.1	2.97E-14	Homocysteine levels	
SARC	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.27	2.84E-5	Body mass index	
SARC	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.38	-5.26	3.23E-7	Body mass index	
SARC	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.4	-5.62	5.31E-8	Body mass index	
SARC	cis	1	rs4687701	chr3:53121276	RFT1	chr3:53122503-53164470:-	0.28	4.21	3.61E-5	Height	
SARC	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.46	-7.04	2.17E-11	Ankylosing spondylitis	
SARC	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.44	5.44	1.37E-7	Ankylosing spondylitis	
SARC	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.53	-8.84	2.3E-16	Response to antipsychotic treatment	
SARC	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.53	-8.91	1.47E-16	Response to antipsychotic treatment	
SARC	cis	1	rs4710147	chr6:167374239	RNASET2	chr6:167343008-167412795:-	0.17	4.05	7.03E-5	Crohn's disease	
SARC	cis	1	rs4715129	chr6:49415043	CENPQ	chr6:49431096-49460820:+	-0.25	-4.45	1.35E-5	Folate pathway vitamin levels	
SARC	cis	1	rs4715130	chr6:49416825	CENPQ	chr6:49431096-49460820:+	-0.24	-4.24	3.16E-5	Folate pathway vitamin levels	
SARC	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.32	6	7.3E-9	Response to temozolomide	
SARC	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.31	5.86	1.58E-8	Response to temozolomide	
SARC	cis	1	rs4741976	chr9:4403259	AK3	chr9:4711158-4742043:-	-0.33	-4.18	4.13E-5	Parental extreme longevity (95 years and older)	
SARC	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.32	-6.07	5.13E-9	Response to temozolomide	
SARC	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.34	-4.45	1.33E-5	Forced vital capacity	
SARC	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.57	-8.88	1.79E-16	Cognitive function	
SARC	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.25	-5.04	9.21E-7	Type 1 diabetes	
SARC	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.3	5.7	3.63E-8	Response to temozolomide	
SARC	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.3	-4.74	3.63E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.32	5.07	8.18E-7	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.32	6.01	6.99E-9	Response to temozolomide	
SARC	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.47	-8.47	2.83E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.49	-9.3	1.03E-17	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.47	-8.57	1.42E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.47	-8.53	1.88E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.47	-8.53	1.88E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.47	-8.47	2.83E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs4801958	chr19:53667804	ZNF665	chr19:53666552-53696619:-	-0.25	-4.07	6.53E-5	Yu-Zhi constitution type in type 2 diabetes	
SARC	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.48	10.12	3.35E-20	Schizophrenia	
SARC	cis	1	rs4803774	chr19:45450872	APOC2	chr19:45449243-45452817:+	-0.25	-5.22	4.03E-7	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs4803774	chr19:45450872	APOC4	chr19:45445495-45448751:+	0.24	4.27	2.86E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs4805834	chr19:33453659	SLC7A9	chr19:33321421-33360683:-	-0.45	-4.58	7.51E-6	Creatinine levels	
SARC	cis	1	rs480643	chr10:131400308	MGMT	chr10:131265454-131565783:+	0.31	5.79	2.29E-8	Response to temozolomide	
SARC	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.3	5.7	3.63E-8	Response to temozolomide	
SARC	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.23	4.9	1.76E-6	Longevity	
SARC	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.25	5.37	1.87E-7	Longevity	
SARC	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.26	-5.67	4.14E-8	Longevity	
SARC	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.26	-5.77	2.52E-8	Longevity	
SARC	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.37	7.82	1.77E-13	Kawasaki disease	
SARC	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1.01	-19.23	4.6E-50	Pediatric autoimmune diseases	
SARC	cis	1	rs4886818	chr15:76880939	SCAPER	chr15:76640529-77197744:-	-0.23	-5.03	9.59E-7	Blood metabolite levels	
SARC	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.21	-4.12	5.27E-5	Testicular germ cell tumor	
SARC	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.37	-7.34	3.51E-12	Common traits (Other)	
SARC	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.37	-7.34	3.51E-12	Common traits (Other)	
SARC	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.37	-7.34	3.51E-12	Common traits (Other)	
SARC	cis	1	rs4905179	chr14:94795492	PPP4R4	chr14:94640649-94746072:+	-0.37	-4.24	3.26E-5	Breast size	
SARC	cis	1	rs4911178	chr20:33952620	CPNE1	chr20:34213968-34262539:-	0.32	4.54	9.16E-6	Height	
SARC	cis	1	rs4911180	chr20:33972948	CPNE1	chr20:34213968-34262539:-	0.33	4.57	7.91E-6	Height	
SARC	cis	1	rs4911491	chr20:33947285	CPNE1	chr20:34213968-34262539:-	0.32	4.48	1.15E-5	Height	
SARC	cis	1	rs4911492	chr20:33951799	CPNE1	chr20:34213968-34262539:-	0.32	4.48	1.15E-5	Height	
SARC	cis	1	rs4911494	chr20:33971914	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs4911496	chr20:33972053	CPNE1	chr20:34213968-34262539:-	-0.33	-4.43	1.43E-5	Height	
SARC	cis	1	rs4925166	chr17:18210810	LOC220594	chr17:18414577-18445234:-	-0.35	-4.97	1.29E-6	Multiple sclerosis	
SARC	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.57	-6.91	4.48E-11	Type 2 diabetes	
SARC	cis	1	rs494003	chr11:65542298	CTSW	chr11:65647284-65651212:+	-0.24	-4.09	5.96E-5	Systemic lupus erythematosus	
SARC	cis	1	rs4951261	chr1:205717823	PM20D1	chr1:205797154-205819245:-	0.28	4.12	5.26E-5	Menarche (age at onset)	
SARC	cis	1	rs4955485	chr3:134295843	CEP63	chr3:134204575-134293852:+	0.33	4.85	2.25E-6	Height	
SARC	cis	1	rs4955555	chr3:134286427	CEP63	chr3:134204575-134293852:+	0.34	4.93	1.54E-6	Height	
SARC	cis	1	rs495572	chr6:13717932	CCDC90A	chr6:13791021-13814789:-	0.27	4.19	3.9E-5	Breast cancer	
SARC	cis	1	rs495633	chr6:13717913	CCDC90A	chr6:13791021-13814789:-	0.27	4.29	2.57E-5	Breast cancer	
SARC	cis	1	rs4958424	chr5:150225036	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs4958842	chr5:150224877	IRGM	chr5:150226085-150280295:+	0.53	4.58	7.52E-6	Crohn's disease	
SARC	cis	1	rs4958843	chr5:150224924	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.59	-6.91	4.49E-11	Diastolic blood pressure	
SARC	cis	1	rs4974483	chr3:134219001	CEP63	chr3:134204575-134293852:+	0.35	5.24	3.53E-7	Height	
SARC	cis	1	rs4974484	chr3:134219019	CEP63	chr3:134204575-134293852:+	0.35	5.13	5.96E-7	Height	
SARC	cis	1	rs4974493	chr3:134219993	CEP63	chr3:134204575-134293852:+	0.35	5.13	5.96E-7	Height	
SARC	cis	1	rs4974559	chr4:1380848	CRIPAK	chr4:1385340-1389782:+	-0.34	-4.73	3.97E-6	Systolic blood pressure	
SARC	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.48	-5.38	1.79E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.48	-5.38	1.79E-7	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.31	5.95	9.63E-9	Response to temozolomide	
SARC	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.32	5.91	1.21E-8	Response to temozolomide	
SARC	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.29	-5.41	1.52E-7	Response to temozolomide	
SARC	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.32	6	7.44E-9	Response to temozolomide	
SARC	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.31	5.93	1.1E-8	Response to temozolomide	
SARC	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.32	-6.16	3.19E-9	Response to temozolomide	
SARC	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.31	5.83	1.81E-8	Response to temozolomide	
SARC	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.31	-5.92	1.14E-8	Response to temozolomide	
SARC	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.32	6.01	7.07E-9	Response to temozolomide	
SARC	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.32	6.02	6.78E-9	Response to temozolomide	
SARC	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.31	5.92	1.13E-8	Response to temozolomide	
SARC	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.3	5.74	2.98E-8	Response to temozolomide	
SARC	cis	1	rs55752096	chr18:48368918	MRO	chr18:48321491-48351754:-	0.4	4.3	2.54E-5	Entorhinal cortical thickness	
SARC	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.39	5.35	2.06E-7	Body mass index	
SARC	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.3	-5.53	8.72E-8	Response to temozolomide	
SARC	cis	1	rs55879323	chr1:152168740	HRNR	chr1:152184558-152196669:-	0.41	5.86	1.59E-8	Inflammatory skin disease	
SARC	cis	1	rs55913793	chr3:134285968	CEP63	chr3:134204575-134293852:+	0.34	4.93	1.54E-6	Height	
SARC	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.67	6.61	2.56E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.53	5.53	8.41E-8	Diastolic blood pressure	
SARC	cis	1	rs56145559	chr2:73623439	ALMS1P	chr2:73872046-73912692:+	0.53	6.51	4.46E-10	Schizophrenia	
SARC	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.45	5.38	1.85E-7	Metabolite levels	
SARC	cis	1	rs56156035	chr2:242205955	ANO7	chr2:242127924-242164791:+	0.4	4.19	3.94E-5	Prostate cancer	
SARC	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.53	5.53	8.41E-8	Diastolic blood pressure	
SARC	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.54	5.16	5.16E-7	Diastolic blood pressure	
SARC	cis	1	rs5629	chr20:48129706	STAU1	chr20:47729878-47805288:-	-0.35	-4.58	7.46E-6	Schizophrenia	
SARC	cis	1	rs56306402	chr20:33937704	CPNE1	chr20:34213968-34262539:-	0.31	4.32	2.26E-5	Height	
SARC	cis	1	rs56383420	chr2:242219281	ANO7	chr2:242127924-242164791:+	0.39	4.11	5.39E-5	Prostate cancer	
SARC	cis	1	rs56390833	chr15:78877381	CHRNA5	chr15:78857906-78886458:+	-0.26	-4.11	5.58E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
SARC	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.3	5.74	2.98E-8	Response to temozolomide	
SARC	cis	1	rs56672945	chr2:73622663	ALMS1P	chr2:73872046-73912692:+	0.53	6.68	1.69E-10	Metabolite levels	
SARC	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.3	5.74	2.98E-8	Response to temozolomide	
SARC	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.58	6.51	4.58E-10	Diastolic blood pressure	
SARC	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.42	-9.92	1.34E-19	Crohn's disease	
SARC	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.33	4.93	1.56E-6	Crohn's disease	
SARC	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.47	-8.53	1.88E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.31	5.9	1.25E-8	Response to temozolomide	
SARC	cis	1	rs571676	chr6:13718872	CCDC90A	chr6:13791021-13814789:-	0.27	4.22	3.49E-5	Breast cancer	
SARC	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	0.64	7.4	2.48E-12	Diastolic blood pressure	
SARC	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.31	5.86	1.55E-8	Response to temozolomide	
SARC	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.31	5.95	9.83E-9	Response to temozolomide	
SARC	cis	1	rs58603761	chr2:73726605	ALMS1P	chr2:73872046-73912692:+	0.43	5.28	2.92E-7	Metabolite levels	
SARC	cis	1	rs590394	chr19:7902505	LRRC8E	chr19:7953390-7966908:+	-0.26	-4.13	5.14E-5	Menarche (age at onset)	
SARC	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.33	4.03	7.58E-5	Pancreatic cancer	
SARC	cis	1	rs59164036	chr3:122362199	ADCY5	chr3:123003399-123167392:-	0.42	4.03	7.49E-5	Acoustic startle blink response	
SARC	cis	1	rs59531858	chr5:150247063	IRGM	chr5:150226085-150280295:+	0.54	4.48	1.16E-5	Crohn's disease	
SARC	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.47	-8.47	2.83E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs5996946	chr22:25875988	CRYBB2	chr22:25615612-25627836:+	0.83	7.73	3.24E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6003958	chr22:24264089	GSTT1	chr22:24376141-24384284:-	-0.72	-8.82	2.61E-16	S-phenylmercapturic acid levels in smokers	
SARC	cis	1	rs6003958	chr22:24264089	GSTT2	chr22:24322314-24326104:+;chr22	0.54	6.42	7.37E-10	S-phenylmercapturic acid levels in smokers	
SARC	cis	1	rs6003958	chr22:24264089	LOC391322	chr22:24373117-24374043:+	-0.62	-8.23	1.27E-14	S-phenylmercapturic acid levels in smokers	
SARC	cis	1	rs60040240	chr17:50181183	CA10	chr17:49707675-50237377:-	0.34	4.23	3.38E-5	Gastritis	
SARC	cis	1	rs6004654	chr22:25855204	CRYBB2	chr22:25615612-25627836:+	0.8	7.37	3.0E-12	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004657	chr22:25855714	CRYBB2	chr22:25615612-25627836:+	0.8	7.45	1.83E-12	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004658	chr22:25856231	CRYBB2	chr22:25615612-25627836:+	0.8	7.37	3.0E-12	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004659	chr22:25856411	CRYBB2	chr22:25615612-25627836:+	0.8	7.48	1.52E-12	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004662	chr22:25862124	CRYBB2	chr22:25615612-25627836:+	0.83	7.55	9.84E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004667	chr22:25874464	CRYBB2	chr22:25615612-25627836:+	-0.8	-7.53	1.12E-12	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004668	chr22:25874502	CRYBB2	chr22:25615612-25627836:+	-0.84	-7.8	2.08E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004669	chr22:25875803	CRYBB2	chr22:25615612-25627836:+	0.83	7.63	5.91E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004671	chr22:25879474	CRYBB2	chr22:25615612-25627836:+	0.84	7.74	2.96E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004672	chr22:25881013	CRYBB2	chr22:25615612-25627836:+	0.83	7.57	8.66E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004673	chr22:25885353	CRYBB2	chr22:25615612-25627836:+	0.81	7.73	3.18E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6004675	chr22:25889385	CRYBB2	chr22:25615612-25627836:+	0.83	7.41	2.22E-12	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs6019876	chr20:48129987	STAU1	chr20:47729878-47805288:-	-0.31	-4.22	3.46E-5	Schizophrenia	
SARC	cis	1	rs604938	chr19:7903484	LRRC8E	chr19:7953390-7966908:+	0.25	4.08	6.08E-5	Menarche (age at onset)	
SARC	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.25	-5.24	3.65E-7	Longevity	
SARC	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.26	4.16	4.42E-5	IFN-related cytopenia	
SARC	cis	1	rs6054973	chr20:7385958	TMX4	chr20:7961716-8000393:-	-0.62	-4.4	1.64E-5	Asthma (childhood onset)	
SARC	cis	1	rs6060401	chr20:34005214	CPNE1	chr20:34213968-34262539:-	0.31	4.25	3.13E-5	Height	
SARC	cis	1	rs6060402	chr20:34005240	CPNE1	chr20:34213968-34262539:-	0.31	4.33	2.21E-5	Height	
SARC	cis	1	rs60844734	chr2:73623205	ALMS1P	chr2:73872046-73912692:+	0.53	6.68	1.69E-10	Metabolite levels	
SARC	cis	1	rs6087698	chr20:33948919	CPNE1	chr20:34213968-34262539:-	0.32	4.48	1.15E-5	Height	
SARC	cis	1	rs6087702	chr20:33995945	CPNE1	chr20:34213968-34262539:-	0.31	4.36	1.98E-5	Height	
SARC	cis	1	rs6087703	chr20:33996433	CPNE1	chr20:34213968-34262539:-	0.3	4.2	3.82E-5	Height	
SARC	cis	1	rs6087704	chr20:34001058	CPNE1	chr20:34213968-34262539:-	0.3	4.23	3.4E-5	Height	
SARC	cis	1	rs6087705	chr20:34001250	CPNE1	chr20:34213968-34262539:-	0.31	4.39	1.74E-5	Height	
SARC	cis	1	rs6088799	chr20:33934301	CPNE1	chr20:34213968-34262539:-	0.32	4.53	9.6E-6	Height	
SARC	cis	1	rs6088812	chr20:33974163	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6088813	chr20:33975181	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6088815	chr20:33976474	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6088816	chr20:33982435	CPNE1	chr20:34213968-34262539:-	0.31	4.4	1.66E-5	Height	
SARC	cis	1	rs6088820	chr20:33987298	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6088821	chr20:33987576	CPNE1	chr20:34213968-34262539:-	0.31	4.35	2.01E-5	Height	
SARC	cis	1	rs6088823	chr20:33994265	CPNE1	chr20:34213968-34262539:-	0.3	4.2	3.82E-5	Height	
SARC	cis	1	rs6088825	chr20:33995972	CPNE1	chr20:34213968-34262539:-	0.31	4.24	3.16E-5	Height	
SARC	cis	1	rs6095557	chr20:48128997	STAU1	chr20:47729878-47805288:-	-0.31	-4.21	3.71E-5	Schizophrenia	
SARC	cis	1	rs60982898	chr6:49385806	CENPQ	chr6:49431096-49460820:+	-0.25	-4.41	1.57E-5	Folate pathway vitamin levels	
SARC	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.38	-4.92	1.63E-6	Forced vital capacity	
SARC	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.25	3.05E-5	Body mass index	
SARC	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.58	-6.5	4.87E-10	Triglycerides	
SARC	cis	1	rs61270113	chr5:150226263	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs61280460	chr14:94796184	PPP4R4	chr14:94640649-94746072:+	-0.37	-4.24	3.26E-5	Breast size	
SARC	cis	1	rs6141546	chr20:33949282	CPNE1	chr20:34213968-34262539:-	0.32	4.48	1.15E-5	Height	
SARC	cis	1	rs6141548	chr20:33971085	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6141549	chr20:33974051	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6142358	chr20:33960308	CPNE1	chr20:34213968-34262539:-	-0.32	-4.43	1.46E-5	Height	
SARC	cis	1	rs6142359	chr20:33960450	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6142360	chr20:33960486	CPNE1	chr20:34213968-34262539:-	0.29	4.1	5.68E-5	Height	
SARC	cis	1	rs6142369	chr20:33973315	CPNE1	chr20:34213968-34262539:-	0.31	4.35	2.01E-5	Height	
SARC	cis	1	rs6142370	chr20:33973378	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6142373	chr20:33983314	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6142374	chr20:33985568	CPNE1	chr20:34213968-34262539:-	0.31	4.35	2.01E-5	Height	
SARC	cis	1	rs6142376	chr20:33992761	CPNE1	chr20:34213968-34262539:-	0.31	4.4	1.66E-5	Height	
SARC	cis	1	rs6142379	chr20:33999267	CPNE1	chr20:34213968-34262539:-	0.3	4.2	3.82E-5	Height	
SARC	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-0.71	-7.22	7.27E-12	Blood metabolite levels	
SARC	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.45	4.67	5.04E-6	Diastolic blood pressure;Blood pressure	
SARC	cis	1	rs61826828	chr1:174015261	SERPINC1	chr1:173872943-173886516:-	0.41	4.99	1.18E-6	Schizophrenia	
SARC	cis	1	rs62070270	chr17:28263980	SUZ12P	chr17:29035714-29097067:+	0.22	4.47	1.23E-5	Coffee consumption (cups per day)	
SARC	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.46	5.59	6.44E-8	Metabolite levels	
SARC	cis	1	rs62211529	chr20:33959315	CPNE1	chr20:34213968-34262539:-	0.3	4.2	3.82E-5	Height	
SARC	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.3	4.12	5.28E-5	Height	
SARC	cis	1	rs62269547	chr3:134214042	CEP63	chr3:134204575-134293852:+	0.36	5.33	2.36E-7	Height	
SARC	cis	1	rs62271513	chr3:134298412	CEP63	chr3:134204575-134293852:+	-0.34	-4.88	2.0E-6	Height	
SARC	cis	1	rs62271514	chr3:134298554	CEP63	chr3:134204575-134293852:+	-0.34	-4.88	2.0E-6	Height	
SARC	cis	1	rs62271515	chr3:134300507	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.45E-6	Height	
SARC	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.42	-9.92	1.34E-19	Crohn's disease	
SARC	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.33	4.93	1.56E-6	Crohn's disease	
SARC	cis	1	rs641862	chr13:110790232	ANKRD10	chr13:111530888-111567416:-	0.57	5.71	3.45E-8	Obesity-related traits	
SARC	cis	1	rs641862	chr13:110790232	ARHGEF7	chr13:111767624-111958080:+	0.71	6.55	3.69E-10	Obesity-related traits	
SARC	cis	1	rs641862	chr13:110790232	CARKD	chr13:111267881-111292340:+	0.88	7.48	1.47E-12	Obesity-related traits	
SARC	cis	1	rs641862	chr13:110790232	CARS2	chr13:111293757-111365950:-	0.79	6.89	5.05E-11	Obesity-related traits	
SARC	cis	1	rs641862	chr13:110790232	ING1	chr13:111365083-111373420:+	0.82	6.75	1.17E-10	Obesity-related traits	
SARC	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.49	6.84	6.9E-11	Height	
SARC	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.54	-8.23	1.31E-14	Homocysteine levels	
SARC	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.48	-7.26	5.67E-12	Homocysteine levels	
SARC	cis	1	rs6435079	chr2:202200331	CASP8	chr2:202098166-202152434:+	0.27	4.15	4.6E-5	Basal cell carcinoma	
SARC	cis	1	rs6439484	chr3:134249899	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs6439487	chr3:134260860	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.26	5.51	9.48E-8	Longevity	
SARC	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.26	-5.72	3.17E-8	Longevity	
SARC	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.26	-5.58	6.65E-8	Longevity	
SARC	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.23	-4.8	2.85E-6	Longevity	
SARC	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.7	7.67	4.48E-13	Type 2 diabetes	
SARC	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.65	7.32	3.89E-12	Type 2 diabetes	
SARC	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.54	9.21	1.97E-17	Response to antipsychotic treatment	
SARC	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.44	-8.35	6.15E-15	Homocysteine levels	
SARC	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.44	-8.34	6.52E-15	Homocysteine levels	
SARC	cis	1	rs6458690	chr6:49411619	CENPQ	chr6:49431096-49460820:+	-0.23	-4.06	6.65E-5	Folate pathway vitamin levels	
SARC	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.26	-4.62	6.4E-6	Folate pathway vitamin levels	
SARC	cis	1	rs6465750	chr7:99235522	COPS6	chr7:99686583-99689820:+	0.38	4.16	4.49E-5	Blood metabolite levels	
SARC	cis	1	rs6465750	chr7:99235522	CYP3A5	chr7:99245818-99332821:-	0.64	5.92	1.14E-8	Blood metabolite levels	
SARC	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.35	4.86	2.19E-6	Erythrocyte sedimentation rate	
SARC	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.38	-4.92	1.61E-6	Erythrocyte sedimentation rate	
SARC	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.43	-5.3	2.74E-7	Rheumatoid arthritis	
SARC	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.41	-5.07	8.13E-7	Rheumatoid arthritis	
SARC	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.4	-5.36	2.02E-7	Forced vital capacity	
SARC	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.37	4.78	3.13E-6	Forced vital capacity	
SARC	cis	1	rs6495206	chr15:76870963	SCAPER	chr15:76640529-77197744:-	-0.22	-4.89	1.88E-6	Blood metabolite levels	
SARC	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.6	-7.32	3.84E-12	Type 2 diabetes	
SARC	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.47	-8.47	2.72E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs6519611	chr22:25845855	CRYBB2	chr22:25615612-25627836:+	0.78	7.15	1.1E-11	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs652260	chr19:7900562	LRRC8E	chr19:7953390-7966908:+	-0.28	-4.52	9.81E-6	Menarche (age at onset)	
SARC	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.27	-6.02	6.59E-9	Longevity	
SARC	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.31	-6.06	5.5E-9	Tuberculosis	
SARC	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.49	7.63	5.98E-13	Tuberculosis	
SARC	cis	1	rs6545883	chr2:61772257	USP34	chr2:61414591-61697849:-	-0.2	-4.03	7.65E-5	Tuberculosis	
SARC	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.45	5.5	9.69E-8	Metabolite levels	
SARC	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.44	5.34	2.23E-7	Metabolite levels	
SARC	cis	1	rs6546837	chr2:73677898	ALMS1P	chr2:73872046-73912692:+	0.45	5.49	1.06E-7	Metabolite levels	
SARC	cis	1	rs6546838	chr2:73679280	ALMS1P	chr2:73872046-73912692:+	0.45	5.49	1.06E-7	Metabolite levels	
SARC	cis	1	rs6546839	chr2:73680508	ALMS1P	chr2:73872046-73912692:+	0.45	5.49	1.06E-7	Metabolite levels	
SARC	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.38	-5.25	3.34E-7	Body mass index	
SARC	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.42	-9.92	1.34E-19	Crohn's disease	
SARC	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.33	4.93	1.56E-6	Crohn's disease	
SARC	cis	1	rs6575154	chr14:91284705	TDP1	chr14:90421283-90511106:+	0.26	4.34	2.08E-5	Anxiety disorder	
SARC	cis	1	rs6579234	chr20:33983485	CPNE1	chr20:34213968-34262539:-	0.32	4.51	1.02E-5	Height	
SARC	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.57	-6.45	6.2E-10	Cholesterol, total	
SARC	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.27	4.33	2.21E-5	Multiple sclerosis	
SARC	cis	1	rs6599170	chr3:41772718	ULK4	chr3:41288091-42003660:-	0.63	7.1	1.48E-11	Diastolic blood pressure	
SARC	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.57	-6.64	2.23E-10	Diastolic blood pressure	
SARC	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.63	-7.1	1.44E-11	Diastolic blood pressure	
SARC	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	0.6	6.88	5.42E-11	Diastolic blood pressure	
SARC	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	0.61	6.93	4.05E-11	Diastolic blood pressure	
SARC	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.55	-8.53	1.8E-15	Homocysteine levels	
SARC	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.25	3.05E-5	Body mass index	
SARC	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.19	4.03E-5	Body mass index	
SARC	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.27	2.84E-5	Body mass index	
SARC	cis	1	rs66871576	chr14:55629050	MAPK1IP1L	chr14:55518362-55536912:+	0.28	4.12	5.28E-5	Protein biomarker	
SARC	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.48	-6.66	1.98E-10	Height	
SARC	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.46	5.89	1.33E-8	Metabolite levels	
SARC	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.34	4.49	1.12E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
SARC	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.45	5.69	3.8E-8	Metabolite levels	
SARC	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.39	-5.36	1.96E-7	Body mass index	
SARC	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.44	-5.43	1.43E-7	Metabolite levels	
SARC	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.4	-5.6	6.03E-8	Body mass index	
SARC	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.42	5.23	3.81E-7	Metabolite levels	
SARC	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.51	-4.36	1.96E-5	Rheumatoid arthritis	
SARC	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.49	-4.28	2.68E-5	Rheumatoid arthritis	
SARC	cis	1	rs6721181	chr2:40115696	SOS1	chr2:39208692-39351486:-	0.63	5.29	2.79E-7	Asthma (childhood onset)	
SARC	cis	1	rs6724782	chr2:73679990	ALMS1P	chr2:73872046-73912692:+	0.45	5.49	1.06E-7	Metabolite levels	
SARC	cis	1	rs6733051	chr2:219084533	AAMP	chr2:219128853-219134893:-	0.61	4.04	7.33E-5	Obesity-related traits	
SARC	cis	1	rs6733051	chr2:219084533	BCS1L	chr2:219523528-219528165:+	0.68	5.09	7.48E-7	Obesity-related traits	
SARC	cis	1	rs6733051	chr2:219084533	STK36	chr2:219536762-219567439:+	0.63	4.75	3.52E-6	Obesity-related traits	
SARC	cis	1	rs6733051	chr2:219084533	USP37	chr2:219314974-219433084:-	0.52	4.57	7.74E-6	Obesity-related traits	
SARC	cis	1	rs6733051	chr2:219084533	ZNF142	chr2:219502644-219524261:-	0.59	4.34	2.1E-5	Obesity-related traits	
SARC	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.47	5.54	7.97E-8	Metabolite levels	
SARC	cis	1	rs6737085	chr2:202221441	CASP8	chr2:202098166-202152434:+	0.26	4.06	6.63E-5	Basal cell carcinoma	
SARC	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.45	5.69	3.8E-8	Metabolite levels	
SARC	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.31	-6.03	6.19E-9	Tuberculosis	
SARC	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.48	7.44	1.92E-12	Tuberculosis	
SARC	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.47	5.88	1.43E-8	Metabolite levels	
SARC	cis	1	rs6752050	chr2:242228780	ANO7	chr2:242127924-242164791:+	0.4	4.11	5.49E-5	Prostate cancer	
SARC	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.41	-5.27	3.09E-7	Metabolite levels	
SARC	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.37	4.48	1.18E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.52	6.6	2.73E-10	Metabolite levels	
SARC	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.49	6.33	1.23E-9	Metabolite levels	
SARC	cis	1	rs6755241	chr2:73641364	NAT8	chr2:73867850-73869537:-	0.33	4.1	5.59E-5	Metabolite levels	
SARC	cis	1	rs6756987	chr2:73687077	ALMS1P	chr2:73872046-73912692:+	0.45	5.49	1.06E-7	Metabolite levels	
SARC	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.44	-7.21	7.86E-12	Triptolide cytotoxicity	
SARC	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.73	-7.98	6.6E-14	Triptolide cytotoxicity	
SARC	cis	1	rs6763088	chr3:134254989	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs6763093	chr3:134254995	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	0.62	7.13	1.22E-11	Diastolic blood pressure	
SARC	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.3	4.11	5.46E-5	Height	
SARC	cis	1	rs6765505	chr3:134208132	CEP63	chr3:134204575-134293852:+	0.36	5.35	2.05E-7	Height	
SARC	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.3	4.11	5.38E-5	Height	
SARC	cis	1	rs6766818	chr3:134226159	CEP63	chr3:134204575-134293852:+	0.36	5.25	3.36E-7	Height	
SARC	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.32	4.27	2.85E-5	Height	
SARC	cis	1	rs6766897	chr3:134191303	CEP63	chr3:134204575-134293852:+	0.35	4.95	1.4E-6	Height	
SARC	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.58	6.51	4.58E-10	Diastolic blood pressure	
SARC	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.59	6.27	1.69E-9	Diastolic blood pressure	
SARC	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.59	6.27	1.69E-9	Diastolic blood pressure	
SARC	cis	1	rs6769885	chr3:134286913	CEP63	chr3:134204575-134293852:+	0.34	4.93	1.54E-6	Height	
SARC	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.25	-5.34	2.25E-7	Longevity	
SARC	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.33	4.35	2.03E-5	Height	
SARC	cis	1	rs6772896	chr3:134203347	CEP63	chr3:134204575-134293852:+	0.36	5.05	9.08E-7	Height	
SARC	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.25	-5.18	4.73E-7	Longevity	
SARC	cis	1	rs6781326	chr3:41777028	ULK4	chr3:41288091-42003660:-	0.62	7.09	1.6E-11	Diastolic blood pressure	
SARC	cis	1	rs6782563	chr3:134295959	CEP63	chr3:134204575-134293852:+	-0.33	-4.85	2.25E-6	Height	
SARC	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.6	6.91	4.63E-11	Diastolic blood pressure	
SARC	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.25	-5.2	4.28E-7	Longevity	
SARC	cis	1	rs6785027	chr3:134211649	CEP63	chr3:134204575-134293852:+	-0.36	-5.34	2.16E-7	Height	
SARC	cis	1	rs6787371	chr3:134254991	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.42E-6	Height	
SARC	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.56	5.66	4.47E-8	Diastolic blood pressure	
SARC	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.33	4.35	2.0E-5	Height	
SARC	cis	1	rs6790466	chr3:134197740	CEP63	chr3:134204575-134293852:+	0.36	5.06	8.34E-7	Height	
SARC	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.37	5.57	7.04E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
SARC	cis	1	rs6793487	chr3:134299426	CEP63	chr3:134204575-134293852:+	-0.33	-4.83	2.45E-6	Height	
SARC	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.24	-5.15	5.58E-7	Longevity	
SARC	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	0.61	6.93	4.05E-11	Diastolic blood pressure	
SARC	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs6797165	chr3:41887777	ULK4	chr3:41288091-42003660:-	0.62	7.13	1.26E-11	Diastolic blood pressure	
SARC	cis	1	rs6800862	chr3:134228628	CEP63	chr3:134204575-134293852:+	0.35	5.26	3.28E-7	Height	
SARC	cis	1	rs6801343	chr3:41767234	ULK4	chr3:41288091-42003660:-	0.6	6.77	1.04E-10	Diastolic blood pressure	
SARC	cis	1	rs6801596	chr3:134252114	CEP63	chr3:134204575-134293852:+	0.33	4.86	2.16E-6	Height	
SARC	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.3	4.12	5.28E-5	Height	
SARC	cis	1	rs6802654	chr3:134217072	CEP63	chr3:134204575-134293852:+	0.36	5.33	2.36E-7	Height	
SARC	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.61	7.08	1.67E-11	Diastolic blood pressure	
SARC	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.61	7.08	1.67E-11	Diastolic blood pressure	
SARC	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.3	4.12	5.2E-5	Height	
SARC	cis	1	rs6804770	chr3:134230234	CEP63	chr3:134204575-134293852:+	0.36	5.34	2.19E-7	Height	
SARC	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.59	6.27	1.69E-9	Diastolic blood pressure	
SARC	cis	1	rs6806417	chr3:134211446	CEP63	chr3:134204575-134293852:+	-0.35	-5.28	2.93E-7	Height	
SARC	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.25	-5.34	2.25E-7	Longevity	
SARC	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.54	-9.02	6.98E-17	Response to antipsychotic treatment	
SARC	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.27	-6.02	6.59E-9	Longevity	
SARC	cis	1	rs6832503	chr4:48028442	CNGA1	chr4:47937996-48018610:-	-0.31	-4.07	6.54E-5	Renal underexcretion gout;Gout	
SARC	cis	1	rs6841898	chr4:24578097	ZCCHC4	chr4:25314396-25372003:+	0.54	4.27	2.79E-5	Myopia (pathological)	
SARC	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.42	9.92	1.42E-19	Crohn's disease	
SARC	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.32	-4.86	2.11E-6	Crohn's disease	
SARC	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.67	7.3	4.42E-12	Type 2 diabetes	
SARC	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.44	-8.52	1.96E-15	Homocysteine levels	
SARC	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.52	-8.7	5.93E-16	Response to antipsychotic treatment	
SARC	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.45	-8.58	1.3E-15	Homocysteine levels	
SARC	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.44	-8.35	6.15E-15	Homocysteine levels	
SARC	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.44	-8.35	6.14E-15	Homocysteine levels	
SARC	cis	1	rs6923124	chr6:49419864	CENPQ	chr6:49431096-49460820:+	-0.24	-4.34	2.11E-5	Folate pathway vitamin levels	
SARC	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.54	9.39	5.74E-18	Response to antipsychotic treatment	
SARC	cis	1	rs6927188	chr6:42912589	GNMT	chr6:42928500-42931617:+	0.37	4.73	3.94E-6	Diabetic kidney disease	
SARC	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.42	-5.15	5.56E-7	Diabetic kidney disease	
SARC	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.41	7.41	2.23E-12	Response to antipsychotic treatment	
SARC	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.53	-9.09	4.44E-17	Response to antipsychotic treatment	
SARC	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.42	-9.92	1.34E-19	Crohn's disease	
SARC	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.33	4.93	1.56E-6	Crohn's disease	
SARC	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.51	-8.39	4.58E-15	Response to antipsychotic treatment	
SARC	cis	1	rs6948775	chr7:98945480	CYP3A5	chr7:99245818-99332821:-	0.63	5.48	1.09E-7	Blood metabolite levels	
SARC	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.42	-9.92	1.34E-19	Crohn's disease	
SARC	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.33	4.93	1.56E-6	Crohn's disease	
SARC	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.83	15.09	2.14E-36	Bone mineral density	
SARC	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.85	15.77	1.19E-38	Bone mineral density	
SARC	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.27	-4.14	4.77E-5	Hematology traits	
SARC	cis	1	rs7025486	chr9:124422403	PTGS1	chr9:125132809-125157981:+	0.32	4.25	3.09E-5	Abdominal aortic aneurysm	
SARC	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.41	-5.07	8.13E-7	Rheumatoid arthritis	
SARC	cis	1	rs7037561	chr9:832711	KANK1	chr9:470294-746104:+	-0.36	-4.32	2.32E-5	Obesity-related traits	
SARC	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.28	-4.57	7.86E-6	Multiple sclerosis	
SARC	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.27	-4.14	4.77E-5	Hematology traits	
SARC	cis	1	rs7040639	chr9:101121741	ANP32B	chr9:100745489-100778222:+	0.52	4.44	1.38E-5	Folate pathway vitamin levels	
SARC	cis	1	rs7045881	chr9:26935996	LRRC19	chr9:26993143-27005691:-	-0.77	-6.06	5.38E-9	Schizophrenia	
SARC	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.59	8.99	8.29E-17	Cognitive function	
SARC	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.47	6.12	3.89E-9	Metabolite levels	
SARC	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.47	-8.49	2.35E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.6	-7.39	2.61E-12	Type 2 diabetes	
SARC	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.38	-4.92	1.63E-6	Forced vital capacity	
SARC	cis	1	rs7129556	chr11:77300048	AQP11	chr11:77300436-77320691:+	-0.36	-4.3	2.54E-5	Weight loss (gastric bypass surgery)	
SARC	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.67	6.36	1.05E-9	Metabolite levels (HVA/5-HIAA ratio)	
SARC	cis	1	rs7133285	chr12:56699429	RPS26	chr12:56435686-56438005:+	0.47	4.14	4.78E-5	Height	
SARC	cis	1	rs7141114	chr14:91286034	TDP1	chr14:90421283-90511106:+	0.25	4.38	1.82E-5	Anxiety disorder	
SARC	cis	1	rs7141336	chr14:91286228	TDP1	chr14:90421283-90511106:+	-0.23	-4.14	4.76E-5	Anxiety disorder	
SARC	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.36	7	2.61E-11	Common traits (Other)	
SARC	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.37	7.39	2.58E-12	Common traits (Other)	
SARC	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.37	-7.37	2.98E-12	Common traits (Other)	
SARC	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.34	4.33	2.19E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	0.35	4.4	1.64E-5	Heschl's gyrus morphology	
SARC	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.34	4.42	1.49E-5	Heschl's gyrus morphology	
SARC	cis	1	rs7167285	chr15:75368769	SCAMP5	chr15:75287901-75313836:+	0.35	4.37	1.83E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs7168680	chr15:75369212	SCAMP5	chr15:75287901-75313836:+	0.35	4.37	1.83E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	0.35	4.4	1.64E-5	Heschl's gyrus morphology	
SARC	cis	1	rs7172118	chr15:78862453	CHRNA5	chr15:78857906-78886458:+	-0.26	-4.17	4.33E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
SARC	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.38	-4.79	2.95E-6	Blood trace element (Zn levels)	
SARC	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.56	8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.32	-5.2	4.33E-7	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs7212497	chr17:28335949	SUZ12P	chr17:29035714-29097067:+	-0.2	-4.06	6.76E-5	Coffee consumption (cups per day)	
SARC	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.56	8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.47	-8.47	2.83E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.57	8.56	1.54E-15	Eye color traits	
SARC	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.56	-8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs7223786	chr17:28332107	SUZ12P	chr17:29035714-29097067:+	-0.2	-4.06	6.76E-5	Coffee consumption (cups per day)	
SARC	cis	1	rs7238284	chr18:48373876	MRO	chr18:48321491-48351754:-	0.4	4.2	3.85E-5	Entorhinal cortical thickness	
SARC	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.25	5.32	2.45E-7	Longevity	
SARC	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.26	5.51	9.46E-8	Longevity	
SARC	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.44	8.64	9.14E-16	Schizophrenia	
SARC	cis	1	rs725908	chr20:33968067	CPNE1	chr20:34213968-34262539:-	0.29	4.1	5.68E-5	Height	
SARC	cis	1	rs72718804	chr14:55630610	MAPK1IP1L	chr14:55518362-55536912:+	0.28	4.15	4.74E-5	Protein biomarker	
SARC	cis	1	rs7274202	chr20:48130982	STAU1	chr20:47729878-47805288:-	-0.33	-4.18	4.13E-5	Schizophrenia	
SARC	cis	1	rs72775522	chr5:88701499	MEF2C	chr5:88014058-88199869:-	0.57	4.22	3.44E-5	Schizophrenia	
SARC	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.4	5.58	6.65E-8	Body mass index	
SARC	cis	1	rs7285549	chr22:25874580	CRYBB2	chr22:25615612-25627836:+	0.85	7.97	7.09E-14	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs72922733	chr11:65520746	CTSW	chr11:65647284-65651212:+	-0.28	-4.68	4.82E-6	Systemic lupus erythematosus	
SARC	cis	1	rs72929710	chr18:48372427	MRO	chr18:48321491-48351754:-	0.4	4.17	4.36E-5	Entorhinal cortical thickness	
SARC	cis	1	rs729824	chr20:48127176	STAU1	chr20:47729878-47805288:-	-0.31	-4.21	3.71E-5	Schizophrenia	
SARC	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.62	6.83	7.37E-11	Diastolic blood pressure	
SARC	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.59	6.83	7.15E-11	Diastolic blood pressure	
SARC	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.59	6.83	7.15E-11	Diastolic blood pressure	
SARC	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.59	6.78	9.81E-11	Diastolic blood pressure	
SARC	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.57	6.52	4.36E-10	Diastolic blood pressure	
SARC	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.53	5.53	8.41E-8	Diastolic blood pressure	
SARC	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.58	6.51	4.58E-10	Diastolic blood pressure	
SARC	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.58	5.87	1.46E-8	Diastolic blood pressure	
SARC	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.58	5.87	1.46E-8	Diastolic blood pressure	
SARC	cis	1	rs73116394	chr2:242367915	SEPT2	chr2:242254723-242293439:+	0.39	4.37	1.84E-5	Chronic lymphocytic leukemia	
SARC	cis	1	rs73116396	chr2:242368693	SEPT2	chr2:242254723-242293439:+	0.39	4.44	1.38E-5	Chronic lymphocytic leukemia	
SARC	cis	1	rs7317330	chr13:100119876	DOCK9	chr13:99445741-99738660:-	0.37	4.17	4.28E-5	Obesity-related traits	
SARC	cis	1	rs732528	chr18:48378234	MRO	chr18:48321491-48351754:-	0.39	4.11	5.45E-5	Entorhinal cortical thickness	
SARC	cis	1	rs73282255	chr5:150223647	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs7338537	chr13:100119581	DOCK9	chr13:99445741-99738660:-	0.37	4.17	4.28E-5	Obesity-related traits	
SARC	cis	1	rs7338761	chr13:100119731	DOCK9	chr13:99445741-99738660:-	0.36	4.04	7.37E-5	Obesity-related traits	
SARC	cis	1	rs73395547	chr7:98922746	CYP3A5	chr7:99245818-99332821:-	0.63	5.48	1.09E-7	Blood metabolite levels	
SARC	cis	1	rs73395557	chr7:98934424	CYP3A5	chr7:99245818-99332821:-	0.63	5.48	1.09E-7	Blood metabolite levels	
SARC	cis	1	rs735531	chr20:33947730	CPNE1	chr20:34213968-34262539:-	0.31	4.32	2.26E-5	Height	
SARC	cis	1	rs7356093	chr3:134238753	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs737008	chr16:11374866	C16orf75	chr16:11343506-11445617:+	0.29	5.23	3.72E-7	Obesity-related traits	
SARC	cis	1	rs7371896	chr3:134249769	CEP63	chr3:134204575-134293852:+	0.33	4.86	2.16E-6	Height	
SARC	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-0.6	-6.98	2.95E-11	Diastolic blood pressure	
SARC	cis	1	rs7374158	chr3:134270156	CEP63	chr3:134204575-134293852:+	0.33	4.79	2.9E-6	Height	
SARC	cis	1	rs7374325	chr3:134275601	CEP63	chr3:134204575-134293852:+	0.34	4.91	1.7E-6	Height	
SARC	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.57	8.53	1.86E-15	Eye color traits	
SARC	cis	1	rs74138464	chr10:45182674	ALOX5	chr10:45869629-45941561:+	0.19	4.09	5.87E-5	Parkinson's disease	
SARC	cis	1	rs7426847	chr3:134267519	CEP63	chr3:134204575-134293852:+	-0.34	-4.86	2.11E-6	Height	
SARC	cis	1	rs7427492	chr3:134261654	CEP63	chr3:134204575-134293852:+	0.34	4.86	2.11E-6	Height	
SARC	cis	1	rs7428326	chr3:134251184	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs7429866	chr3:134236306	CEP63	chr3:134204575-134293852:+	-0.34	-4.95	1.4E-6	Height	
SARC	cis	1	rs7432268	chr3:134242051	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.47E-6	Height	
SARC	cis	1	rs7433663	chr3:134235790	CEP63	chr3:134204575-134293852:+	0.34	5.04	9.15E-7	Height	
SARC	cis	1	rs7433991	chr3:134312292	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.45E-6	Height	
SARC	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.26	-5.83	1.84E-8	Longevity	
SARC	cis	1	rs74363821	chr6:26189524	HIST1H3E	chr6:26224427-26226589:+	0.58	5.44	1.36E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs74472821	chr10:45234562	ALOX5	chr10:45869629-45941561:+	0.21	4.24	3.2E-5	Parkinson's disease	
SARC	cis	1	rs74723905	chr10:45169141	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs74727988	chr10:45176197	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.32	-6.01	7.25E-9	Response to temozolomide	
SARC	cis	1	rs74918362	chr10:45172072	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.56	8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs7504022	chr17:50202877	CA10	chr17:49707675-50237377:-	0.37	4.54	8.93E-6	Gastritis	
SARC	cis	1	rs75071288	chr5:150224379	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.11	5.43E-5	Body mass index	
SARC	cis	1	rs75189511	chr10:45172498	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.37	1.9E-5	Body mass index	
SARC	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.5	7.3	4.46E-12	Homocysteine levels	
SARC	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	0.32	4.25	3.06E-5	Heschl's gyrus morphology	
SARC	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.28	6.56	3.51E-10	Type 1 diabetes autoantibodies	
SARC	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.56	-8.58	1.36E-15	Homocysteine levels	
SARC	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.54	-8.31	7.74E-15	Homocysteine levels	
SARC	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.47	6.58	3.03E-10	Height	
SARC	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.26	4.15	4.62E-5	Body mass index	
SARC	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.22	3.47E-5	Body mass index	
SARC	cis	1	rs7557535	chr2:242206555	ANO7	chr2:242127924-242164791:+	0.4	4.19	3.94E-5	Prostate cancer	
SARC	cis	1	rs7558944	chr2:73810909	ALMS1P	chr2:73872046-73912692:+	0.47	5.89	1.32E-8	Metabolite levels	
SARC	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.4	5.52	8.79E-8	Body mass index	
SARC	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.45	5.85	1.65E-8	Metabolite levels	
SARC	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.44	5.26	3.27E-7	Metabolite levels	
SARC	cis	1	rs7576245	chr2:73829678	ALMS1P	chr2:73872046-73912692:+	0.44	5.6	6.1E-8	Metabolite levels	
SARC	cis	1	rs75774363	chr5:150223722	IRGM	chr5:150226085-150280295:+	0.51	4.66	5.28E-6	Crohn's disease	
SARC	cis	1	rs75792550	chr10:45243814	ALOX5	chr10:45869629-45941561:+	0.21	4.24	3.2E-5	Parkinson's disease	
SARC	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.38	-5.3	2.67E-7	Body mass index	
SARC	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.35	4.58	7.42E-6	Breast cancer (estrogen-receptor negative);Breast cancer	
SARC	cis	1	rs7580825	chr2:73635148	ALMS1P	chr2:73872046-73912692:+	0.52	6.48	5.34E-10	Metabolite levels	
SARC	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.37	7.39	2.58E-12	Common traits (Other)	
SARC	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.47	6.02	6.84E-9	Metabolite levels	
SARC	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.46	5.84	1.7E-8	Metabolite levels	
SARC	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.42	5.23	3.83E-7	Metabolite levels	
SARC	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.47	5.6	6.07E-8	Metabolite levels	
SARC	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.46	5.84	1.7E-8	Metabolite levels	
SARC	cis	1	rs7591472	chr2:201889751	CFLAR	chr2:201980816-202029001:+	-0.44	-7.2	8.09E-12	Triptolide cytotoxicity	
SARC	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.83	-9.76	4.13E-19	Triptolide cytotoxicity	
SARC	cis	1	rs75921373	chr6:26191843	HIST1H3E	chr6:26224427-26226589:+	0.58	5.45	1.26E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.46	5.58	6.47E-8	Metabolite levels	
SARC	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.48	6.09	4.64E-9	Metabolite levels	
SARC	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.47	5.82	1.9E-8	Metabolite levels	
SARC	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.41	-5.7	3.61E-8	Body mass index	
SARC	cis	1	rs76038164	chr10:45170123	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs7604682	chr2:73788026	ALMS1P	chr2:73872046-73912692:+	0.46	5.77	2.52E-8	Metabolite levels	
SARC	cis	1	rs760554	chr22:25872592	CRYBB2	chr22:25615612-25627836:+	0.89	8.08	3.49E-14	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs760555	chr22:25872837	CRYBB2	chr22:25615612-25627836:+	0.83	7.63	6.05E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.41	-4.99	1.17E-6	Metabolite levels	
SARC	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.33	-5.03	9.64E-7	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
SARC	cis	1	rs7611611	chr3:134307877	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.45E-6	Height	
SARC	cis	1	rs7611828	chr3:134250325	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.61	-6.73	1.27E-10	Blood pressure (smoking interaction)	
SARC	cis	1	rs7615974	chr3:122361684	ADCY5	chr3:123003399-123167392:-	0.42	4.03	7.49E-5	Acoustic startle blink response	
SARC	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.63	6.73	1.3E-10	Blood pressure (smoking interaction)	
SARC	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.62	7.13	1.22E-11	Diastolic blood pressure	
SARC	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.61	-7.09	1.56E-11	Diastolic blood pressure	
SARC	cis	1	rs7619451	chr3:134233238	CEP63	chr3:134204575-134293852:+	0.38	5.12	6.44E-7	Height	
SARC	cis	1	rs76209596	chr10:45171209	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.82E-11	Diastolic blood pressure	
SARC	cis	1	rs76306608	chr10:45193129	ALOX5	chr10:45869629-45941561:+	0.19	4.16	4.41E-5	Parkinson's disease	
SARC	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.25	-5.3	2.69E-7	Longevity	
SARC	cis	1	rs7630874	chr3:134293291	CEP63	chr3:134204575-134293852:+	-0.34	-4.84	2.34E-6	Height	
SARC	cis	1	rs7631057	chr3:41817951	ULK4	chr3:41288091-42003660:-	0.62	7.1	1.48E-11	Diastolic blood pressure	
SARC	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.54	5.87	1.5E-8	Diastolic blood pressure	
SARC	cis	1	rs76329209	chr6:26196430	HIST1H3E	chr6:26224427-26226589:+	0.58	5.46	1.23E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.26	-5.6	5.93E-8	Longevity	
SARC	cis	1	rs7634528	chr3:177766464	TBL1XR1	chr3:176738543-176915048:-	-0.59	-4.83	2.49E-6	Myopia (pathological)	
SARC	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.23	-4.72	4.14E-6	Longevity	
SARC	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.24	-5.12	6.4E-7	Longevity	
SARC	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.23	-4.68	4.86E-6	Longevity	
SARC	cis	1	rs7637227	chr3:134244155	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs76375240	chr10:45168370	ALOX5	chr10:45869629-45941561:+	0.2	4.32	2.27E-5	Parkinson's disease	
SARC	cis	1	rs76425893	chr10:45165070	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs7645295	chr3:134307734	CEP63	chr3:134204575-134293852:+	0.33	4.71	4.33E-6	Height	
SARC	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.54	5.87	1.5E-8	Diastolic blood pressure	
SARC	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	0.64	7.37	2.9E-12	Diastolic blood pressure	
SARC	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	0.58	6.68	1.7E-10	Diastolic blood pressure	
SARC	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.62	7.06	1.86E-11	Diastolic blood pressure	
SARC	cis	1	rs7648990	chr3:134244390	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.65	7.52	1.17E-12	Diastolic blood pressure	
SARC	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.27	-5.73	3.1E-8	Longevity	
SARC	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.25	5.32	2.45E-7	Longevity	
SARC	cis	1	rs76548544	chr5:150223515	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs7655841	chr4:129890790	C4orf33	chr4:130014829-130033842:+	0.51	5.81	2.05E-8	Chronic obstructive pulmonary disease (moderate to severe)	
SARC	cis	1	rs76639976	chr10:45169583	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs76713060	chr10:45193795	ALOX5	chr10:45869629-45941561:+	0.2	4.14	4.88E-5	Parkinson's disease	
SARC	cis	1	rs76722536	chr6:26192946	HIST1H3E	chr6:26224427-26226589:+	0.57	5.19	4.65E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.67	6.61	2.56E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs76966968	chr10:45239794	ALOX5	chr10:45869629-45941561:+	0.21	4.24	3.2E-5	Parkinson's disease	
SARC	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	0.35	4.25	3.13E-5	Heschl's gyrus morphology	
SARC	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.13	24.16	1.66E-65	Birdshot chorioretinopathy	
SARC	cis	1	rs7705542	chr5:150228318	IRGM	chr5:150226085-150280295:+	0.5	4.54	9.03E-6	Crohn's disease	
SARC	cis	1	rs77067197	chr10:45168448	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.71	6.44	6.68E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs77264703	chr10:45168809	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs77295349	chr10:45166470	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs77319221	chr11:56911264	P2RX3	chr11:57105949-57137548:+	0.43	4.23	3.32E-5	Low high density lipoprotein cholesterol levels	
SARC	cis	1	rs77444088	chr10:45164272	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs77462963	chr10:45170612	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.53	-8.91	1.47E-16	Response to antipsychotic treatment	
SARC	cis	1	rs7750918	chr6:49430082	CENPQ	chr6:49431096-49460820:+	-0.25	-4.36	1.98E-5	Folate pathway vitamin levels	
SARC	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	0.39	4.73	3.89E-6	Heschl's gyrus morphology	
SARC	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.51	-8.41	4.15E-15	Response to antipsychotic treatment	
SARC	cis	1	rs7759001	chr6:27341409	ZNF391	chr6:27356524-27369227:+	0.31	4.78	3.13E-6	Glomerular filtration rate (creatinine)	
SARC	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.45	-8.57	1.38E-15	Homocysteine levels	
SARC	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.53	-8.88	1.77E-16	Response to antipsychotic treatment	
SARC	cis	1	rs7765586	chr6:152949109	FBXO5	chr6:153291660-153304740:-	-0.2	-4.35	2.05E-5	Tonometry	
SARC	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.53	-8.91	1.47E-16	Response to antipsychotic treatment	
SARC	cis	1	rs776746	chr7:99270539	ARPC1B	chr7:98972329-98992402:+	-0.27	-4.17	4.23E-5	Blood metabolite levels	
SARC	cis	1	rs776746	chr7:99270539	COPS6	chr7:99686583-99689820:+	-0.37	-4.05	6.91E-5	Blood metabolite levels	
SARC	cis	1	rs776746	chr7:99270539	CYP3A5	chr7:99245818-99332821:-	-0.64	-5.8	2.16E-8	Blood metabolite levels	
SARC	cis	1	rs7770848	chr6:44769237	AARS2	chr6:44266463-44281063:-	-0.43	-4.31	2.36E-5	Asthma (childhood onset)	
SARC	cis	1	rs7770848	chr6:44769237	CDC5L	chr6:44355302-44414779:+	-0.44	-5.65	4.6E-8	Asthma (childhood onset)	
SARC	cis	1	rs7770848	chr6:44769237	MRPL14	chr6:44081374-44095191:-	-0.32	-4.38	1.76E-5	Asthma (childhood onset)	
SARC	cis	1	rs7770848	chr6:44769237	SLC35B2	chr6:44221839-44225283:-	-0.5	-5.24	3.54E-7	Asthma (childhood onset)	
SARC	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.51	-8.41	4.15E-15	Response to antipsychotic treatment	
SARC	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.44	-8.35	6.15E-15	Homocysteine levels	
SARC	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.31	-6.05	5.81E-9	Tuberculosis	
SARC	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.48	7.48	1.5E-12	Tuberculosis	
SARC	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.3	-5.91	1.19E-8	Tuberculosis	
SARC	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.47	7.35	3.39E-12	Tuberculosis	
SARC	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.31	-6.05	5.82E-9	Tuberculosis	
SARC	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.48	7.55	9.93E-13	Tuberculosis	
SARC	cis	1	rs77957229	chr6:26185226	HIST1H3E	chr6:26224427-26226589:+	0.57	5.04	9.43E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs77961951	chr6:26186075	HIST1H3E	chr6:26224427-26226589:+	0.57	5.03	9.93E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs78012445	chr6:26195080	HIST1H3E	chr6:26224427-26226589:+	0.58	5.44	1.33E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs78027130	chr4:171019411	AADAT	chr4:170981374-171011372:-	-0.43	-4.16	4.55E-5	Thyroid hormone levels	
SARC	cis	1	rs78059782	chr10:45166935	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs78064157	chr10:45177669	ALOX5	chr10:45869629-45941561:+	0.2	4.19	4.01E-5	Parkinson's disease	
SARC	cis	1	rs7808022	chr7:99220083	CYP3A5	chr7:99245818-99332821:-	0.61	5.48	1.09E-7	Blood metabolite levels	
SARC	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	0.39	4.73	3.89E-6	Heschl's gyrus morphology	
SARC	cis	1	rs78517999	chr10:45175996	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.13	5.06E-5	Body mass index	
SARC	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.11	5.48E-5	Body mass index	
SARC	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.25	-4.03	7.41E-5	Body mass index	
SARC	cis	1	rs78580258	chr10:45171115	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	0.32	4.25	3.06E-5	Heschl's gyrus morphology	
SARC	cis	1	rs7868228	chr9:21667762	CDKN2A	chr9:21967752-21994490:-	0.35	4.45	1.31E-5	Gut microbiome composition (winter)	
SARC	cis	1	rs7868228	chr9:21667762	KLHL9	chr9:21324054-21335429:-	0.38	5.11	6.63E-7	Gut microbiome composition (winter)	
SARC	cis	1	rs7868228	chr9:21667762	MTAP	chr9:21802635-22029593:+	0.35	4.4	1.65E-5	Gut microbiome composition (winter)	
SARC	cis	1	rs78717904	chr10:45232954	ALOX5	chr10:45869629-45941561:+	0.21	4.24	3.2E-5	Parkinson's disease	
SARC	cis	1	rs78853794	chr10:45169838	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	0.35	4.4	1.63E-5	Heschl's gyrus morphology	
SARC	cis	1	rs79108494	chr10:45169186	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.54	9.39	5.6E-18	Response to antipsychotic treatment	
SARC	cis	1	rs79264785	chr6:26194121	HIST1H3E	chr6:26224427-26226589:+	0.58	5.46	1.23E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs7927156	chr11:970607	CD151	chr11:832952-838834:+	0.22	4.09	5.86E-5	Alzheimer's disease (late onset)	
SARC	cis	1	rs79372308	chr10:45172332	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	0.64	7.37	2.9E-12	Diastolic blood pressure	
SARC	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.69	6.7	1.5E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.7	6.49	5.02E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs7973719	chr12:7334813	PEX5	chr12:7341759-7371167:+	0.27	4.54	9.19E-6	IgG glycosylation	
SARC	cis	1	rs79866832	chr10:45172157	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs79868973	chr6:26189312	HIST1H3E	chr6:26224427-26226589:+	0.59	5.34	2.16E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs8005254	chr14:91286609	TDP1	chr14:90421283-90511106:+	0.24	4.22	3.51E-5	Anxiety disorder	
SARC	cis	1	rs80075680	chr5:150223737	IRGM	chr5:150226085-150280295:+	0.5	4.54	8.99E-6	Crohn's disease	
SARC	cis	1	rs80085676	chr2:242347907	SEPT2	chr2:242254723-242293439:+	0.39	4.43	1.48E-5	Chronic lymphocytic leukemia	
SARC	cis	1	rs80095925	chr6:26184942	HIST1H3E	chr6:26224427-26226589:+	0.59	5.19	4.46E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs8019191	chr14:91285507	TDP1	chr14:90421283-90511106:+	0.25	4.29	2.59E-5	Anxiety disorder	
SARC	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.7	6.49	5.02E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs80248291	chr10:45174601	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs80259160	chr6:26190199	HIST1H3E	chr6:26224427-26226589:+	0.58	5.45	1.26E-7	Renal underexcretion gout;Gout	
SARC	cis	1	rs80285556	chr19:50540170	SIGLEC16	chr19:50472912-50479075:+	0.67	6.4	8.23E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.71	6.81	8.26E-11	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
SARC	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.58	-6.98	2.94E-11	Type 2 diabetes	
SARC	cis	1	rs8033837	chr15:75353975	SCAMP5	chr15:75287901-75313836:+	0.38	4.71	4.27E-6	Blood trace element (Zn levels)	
SARC	cis	1	rs8033938	chr15:40703114	C15orf23	chr15:40674922-40686488:+	0.32	4.05	7.04E-5	Heschl's gyrus morphology	
SARC	cis	1	rs80339448	chr10:45166754	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs8034191	chr15:78806023	CHRNA5	chr15:78857906-78886458:+	-0.25	-4.04	7.28E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
SARC	cis	1	rs8036197	chr15:75370232	SCAMP5	chr15:75287901-75313836:+	0.35	4.37	1.83E-5	Blood trace element (Zn levels)	
SARC	cis	1	rs8049173	chr16:11436882	C16orf75	chr16:11343506-11445617:+	0.32	5.2	4.29E-7	Vein graft stenosis in coronary artery bypass grafting	
SARC	cis	1	rs8055427	chr16:11436883	C16orf75	chr16:11343506-11445617:+	0.32	5.2	4.29E-7	Vein graft stenosis in coronary artery bypass grafting	
SARC	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.3	4.77	3.28E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs8065669	chr17:45724996	C17orf57	chr17:45401142-45518675:+	0.29	4.68	4.96E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.47	-8.47	2.72E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs8071789	chr17:38006333	GSDMA	chr17:38119226-38134019:+	0.32	5.57	6.86E-8	Selective IgA deficiency	
SARC	cis	1	rs8072100	chr17:45674687	C17orf57	chr17:45401142-45518675:+	-0.31	-4.96	1.36E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
SARC	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.33	-4.31	2.4E-5	Metabolite levels	
SARC	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.47	-8.55	1.64E-15	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
SARC	cis	1	rs8093534	chr18:48368020	MRO	chr18:48321491-48351754:-	0.4	4.3	2.54E-5	Entorhinal cortical thickness	
SARC	cis	1	rs8121749	chr20:48128589	STAU1	chr20:47729878-47805288:-	-0.31	-4.21	3.71E-5	Schizophrenia	
SARC	cis	1	rs8180991	chr8:126500350	KIAA0196	chr8:126036505-126104061:-	-0.3	-4.09	5.96E-5	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
SARC	cis	1	rs8180991	chr8:126500350	NDUFB9	chr8:125551343-125580751:+	-0.27	-4.51	1.01E-5	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
SARC	cis	1	rs8180991	chr8:126500350	TATDN1	chr8:125500735-125551329:-	-0.29	-4.31	2.45E-5	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	
SARC	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.27	4.28	2.78E-5	Multiple sclerosis	
SARC	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.68	7.53	1.12E-12	Type 2 diabetes	
SARC	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.66	7.3	4.57E-12	Type 2 diabetes	
SARC	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.69	7.71	3.63E-13	Type 2 diabetes	
SARC	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.69	-7.69	4.06E-13	Type 2 diabetes	
SARC	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.44	-8.34	6.52E-15	Homocysteine levels	
SARC	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.7	-7.8	1.98E-13	Type 2 diabetes	
SARC	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.65	6.93	4.0E-11	Type 2 diabetes	
SARC	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.69	7.59	7.56E-13	Type 2 diabetes	
SARC	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.38	7.54	1.03E-12	Kawasaki disease	
SARC	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.58	-9.23	1.72E-17	Cognitive function	
SARC	cis	1	rs877710	chr12:109993976	MYO1H	chr12:109826524-109886176:+	0.32	4.45	1.32E-5	HDL cholesterol	
SARC	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.43	-5.3	2.74E-7	Rheumatoid arthritis	
SARC	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.53	-8.17	1.93E-14	Homocysteine levels	
SARC	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.53	-9.08	4.59E-17	Response to antipsychotic treatment	
SARC	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.26	-4.04	7.34E-5	Height	
SARC	cis	1	rs892055	chr19:38912764	PSMD8	chr19:38865190-38874463:+	0.31	4.75	3.56E-6	Asperger disorder	
SARC	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.25	5.37	1.93E-7	Longevity	
SARC	cis	1	rs913246	chr13:40948151	FOXO1	chr13:41048131-41240734:-	0.42	4.09	5.96E-5	Bipolar disorder and schizophrenia	
SARC	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.26	4.86	2.17E-6	Type 1 diabetes	
SARC	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.23	4.66	5.28E-6	Longevity	
SARC	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.68	7.4	2.47E-12	Type 2 diabetes	
SARC	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.65	6.73	1.3E-10	Blood pressure (smoking interaction)	
SARC	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.3	4.14	4.87E-5	Height	
SARC	cis	1	rs9289471	chr3:134230811	CEP63	chr3:134204575-134293852:+	0.36	5.34	2.2E-7	Height	
SARC	cis	1	rs9289475	chr3:134236459	CEP63	chr3:134204575-134293852:+	0.34	5.04	9.15E-7	Height	
SARC	cis	1	rs9289476	chr3:134237103	CEP63	chr3:134204575-134293852:+	0.33	4.95	1.43E-6	Height	
SARC	cis	1	rs9289478	chr3:134268619	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.5E-6	Height	
SARC	cis	1	rs9296616	chr6:49414235	CENPQ	chr6:49431096-49460820:+	-0.24	-4.24	3.16E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.25	-4.44	1.41E-5	Folate pathway vitamin levels	
SARC	cis	1	rs929843	chr16:70045748	PDXDC2	chr16:70010210-70099851:-	-0.3	-4.42	1.54E-5	Menarche (age at onset)	
SARC	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.26	-5.83	1.84E-8	Longevity	
SARC	cis	1	rs9309331	chr2:61141615	AHSA2	chr2:61404553-61414058:+	-0.26	-4.85	2.25E-6	Inflammatory skin disease	
SARC	cis	1	rs9309331	chr2:61141615	C2orf74	chr2:61372243-61391964:+	0.44	6.47	5.55E-10	Inflammatory skin disease	
SARC	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.43	5.29	2.87E-7	Metabolite levels	
SARC	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	0.62	7.2	8.24E-12	Diastolic blood pressure	
SARC	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.26	-5.6	5.93E-8	Longevity	
SARC	cis	1	rs932644	chr6:167404187	RNASET2	chr6:167343008-167412795:-	-0.18	-4.12	5.24E-5	Crohn's disease	
SARC	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.33	4.35	2.0E-5	Height	
SARC	cis	1	rs934093	chr3:134195885	CEP63	chr3:134204575-134293852:+	0.36	5.06	8.34E-7	Height	
SARC	cis	1	rs934366	chr2:23732893	SF3B14	chr2:24290455-24299314:-	0.29	4.57	7.82E-6	Schizophrenia	
SARC	cis	1	rs9357037	chr6:27327349	ZNF391	chr6:27356524-27369227:+	0.31	4.67	5.16E-6	Glomerular filtration rate (creatinine)	
SARC	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.44	-8.35	6.15E-15	Homocysteine levels	
SARC	cis	1	rs9371626	chr6:153008926	FBXO5	chr6:153291660-153304740:-	-0.21	-4.48	1.18E-5	Tonometry	
SARC	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.45	8.2	1.62E-14	Homocysteine levels	
SARC	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.44	-8.42	3.7E-15	Homocysteine levels	
SARC	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.61	-7.09	1.56E-11	Diastolic blood pressure	
SARC	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.03	7.41E-5	Body mass index	
SARC	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.29	6.8	8.57E-11	Type 1 diabetes autoantibodies	
SARC	cis	1	rs9457247	chr6:167392174	RNASET2	chr6:167343008-167412795:-	-0.17	-4.09	5.84E-5	Crohn's disease	
SARC	cis	1	rs9463473	chr6:49380121	CENPQ	chr6:49431096-49460820:+	-0.25	-4.41	1.57E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9463474	chr6:49380199	CENPQ	chr6:49431096-49460820:+	-0.25	-4.41	1.57E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.26	4.59	7.27E-6	Folate pathway vitamin levels	
SARC	cis	1	rs9463477	chr6:49386446	CENPQ	chr6:49431096-49460820:+	-0.25	-4.41	1.57E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.44	-8.4	4.27E-15	Homocysteine levels	
SARC	cis	1	rs9463479	chr6:49393275	CENPQ	chr6:49431096-49460820:+	-0.25	-4.41	1.57E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9463480	chr6:49400795	CENPQ	chr6:49431096-49460820:+	-0.24	-4.21	3.71E-5	Folate pathway vitamin levels	
SARC	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.26	-4.17	4.22E-5	Body mass index	
SARC	cis	1	rs9473549	chr6:49380020	CENPQ	chr6:49431096-49460820:+	-0.25	-4.23	3.34E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.45	-8.67	7.21E-16	Homocysteine levels	
SARC	cis	1	rs9473552	chr6:49387154	CENPQ	chr6:49431096-49460820:+	-0.25	-4.41	1.57E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9473553	chr6:49395977	CENPQ	chr6:49431096-49460820:+	-0.25	-4.33	2.17E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9473555	chr6:49409487	CENPQ	chr6:49431096-49460820:+	-0.24	-4.17	4.26E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.25	-4.44	1.41E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.25	-4.45	1.3E-5	Folate pathway vitamin levels	
SARC	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.26	-4.42	1.49E-5	Folate pathway vitamin levels	
SARC	cis	1	rs951366	chr1:205685352	PM20D1	chr1:205797154-205819245:-	-0.29	-4.38	1.77E-5	Menarche (age at onset)	
SARC	cis	1	rs9527	chr10:104623578	AS3MT	chr10:104613967-104661653:+	-0.35	-5.38	1.76E-7	Arsenic metabolism	
SARC	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.26	-4.33	2.2E-5	Arsenic metabolism	
SARC	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.54	9.57	1.6E-18	Response to antipsychotic treatment	
SARC	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.53	-9.05	5.58E-17	Response to antipsychotic treatment	
SARC	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.54	-8.7	6.02E-16	Response to antipsychotic treatment	
SARC	cis	1	rs9593	chr12:109994870	MYO1H	chr12:109826524-109886176:+	0.3	4.22	3.45E-5	HDL cholesterol	
SARC	cis	1	rs9624834	chr22:25846015	CRYBB2	chr22:25615612-25627836:+	0.8	7.52	1.18E-12	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs9624835	chr22:25846021	CRYBB2	chr22:25615612-25627836:+	0.8	7.52	1.18E-12	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs9624836	chr22:25846087	CRYBB2	chr22:25615612-25627836:+	0.8	7.43	2.05E-12	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs9635324	chr15:40703211	DISP2	chr15:40650434-40663256:+	0.31	4.32	2.32E-5	Blood metabolite levels;Blood metabolite ratios	
SARC	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.53	-8.91	1.47E-16	Response to antipsychotic treatment	
SARC	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.46	5.84	1.7E-8	Metabolite levels	
SARC	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.56	8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs967989	chr10:45173175	ALOX5	chr10:45869629-45941561:+	0.19	4.13	4.99E-5	Parkinson's disease	
SARC	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.33	4.74	3.72E-6	Erythrocyte sedimentation rate	
SARC	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.35	-4.73	3.83E-6	Erythrocyte sedimentation rate	
SARC	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.56	8.55	1.66E-15	Eye color traits	
SARC	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.55	8.3	8.37E-15	Eye color traits	
SARC	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.4	5.18	4.88E-7	Forced vital capacity	
SARC	cis	1	rs9809619	chr3:134280948	CEP63	chr3:134204575-134293852:+	0.34	4.93	1.54E-6	Height	
SARC	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs9812588	chr3:122363313	ADCY5	chr3:123003399-123167392:-	0.42	4.03	7.49E-5	Acoustic startle blink response	
SARC	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.28	5.89	1.32E-8	Longevity	
SARC	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.3	4.12	5.2E-5	Height	
SARC	cis	1	rs9813774	chr3:134227100	CEP63	chr3:134204575-134293852:+	0.36	5.34	2.19E-7	Height	
SARC	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.31	-4.16	4.39E-5	Height	
SARC	cis	1	rs9814567	chr3:134218557	CEP63	chr3:134204575-134293852:+	-0.35	-5.13	5.97E-7	Height	
SARC	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.25	-5.25	3.46E-7	Longevity	
SARC	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.58	5.87	1.46E-8	Diastolic blood pressure	
SARC	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.24	-5.06	8.68E-7	Longevity	
SARC	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.58	6.38	9.44E-10	Diastolic blood pressure	
SARC	cis	1	rs9819532	chr3:134288644	CEP63	chr3:134204575-134293852:+	0.34	4.93	1.54E-6	Height	
SARC	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.58	5.87	1.46E-8	Diastolic blood pressure	
SARC	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.58	5.87	1.46E-8	Diastolic blood pressure	
SARC	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.58	-6.87	5.92E-11	Diastolic blood pressure	
SARC	cis	1	rs9826058	chr3:41762062	ULK4	chr3:41288091-42003660:-	0.63	7.19	8.84E-12	Diastolic blood pressure	
SARC	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs9826496	chr3:134224437	CEP63	chr3:134204575-134293852:+	0.35	5.09	7.5E-7	Height	
SARC	cis	1	rs9827987	chr3:134272621	CEP63	chr3:134204575-134293852:+	0.34	4.86	2.11E-6	Height	
SARC	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs9828815	chr3:134265749	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.3	4.11	5.38E-5	Height	
SARC	cis	1	rs9829092	chr3:134229866	CEP63	chr3:134204575-134293852:+	0.36	5.25	3.36E-7	Height	
SARC	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.63	7.26	5.81E-12	Diastolic blood pressure	
SARC	cis	1	rs9830469	chr3:41762535	ULK4	chr3:41288091-42003660:-	0.61	6.93	4.08E-11	Diastolic blood pressure	
SARC	cis	1	rs9832785	chr3:134213070	CEP63	chr3:134204575-134293852:+	0.35	5.12	6.43E-7	Height	
SARC	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	0.57	6.55	3.69E-10	Diastolic blood pressure	
SARC	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.31	4.17	4.33E-5	Height	
SARC	cis	1	rs9834755	chr3:134206845	CEP63	chr3:134204575-134293852:+	0.36	5.13	6.07E-7	Height	
SARC	cis	1	rs9835204	chr3:134261342	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.25	-5.11	6.7E-7	Longevity	
SARC	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-0.6	-7.05	1.98E-11	Diastolic blood pressure	
SARC	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-0.6	-7.05	1.98E-11	Diastolic blood pressure	
SARC	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	0.58	6.64	2.2E-10	Diastolic blood pressure	
SARC	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.82E-11	Diastolic blood pressure	
SARC	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.33	4.48	1.19E-5	Height	
SARC	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.35	5.16	5.18E-7	Height	
SARC	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.49	-5.55	7.57E-8	Diastolic blood pressure	
SARC	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-0.61	-7	2.76E-11	Diastolic blood pressure	
SARC	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.58	5.87	1.46E-8	Diastolic blood pressure	
SARC	cis	1	rs9847006	chr3:41755359	ULK4	chr3:41288091-42003660:-	0.62	6.96	3.45E-11	Diastolic blood pressure	
SARC	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.56	5.87	1.48E-8	Diastolic blood pressure	
SARC	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.25	-5.24	3.65E-7	Longevity	
SARC	cis	1	rs9850015	chr3:134269541	CEP63	chr3:134204575-134293852:+	0.34	4.86	2.11E-6	Height	
SARC	cis	1	rs9851441	chr3:134315091	CEP63	chr3:134204575-134293852:+	0.34	5.01	1.09E-6	Height	
SARC	cis	1	rs9852303	chr3:41759525	ULK4	chr3:41288091-42003660:-	0.62	7.01	2.55E-11	Diastolic blood pressure	
SARC	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.31	4.26	2.93E-5	Height	
SARC	cis	1	rs9854299	chr3:134206728	CEP63	chr3:134204575-134293852:+	0.36	5.37	1.92E-7	Height	
SARC	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.56	5.61	5.58E-8	Diastolic blood pressure	
SARC	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	0.61	7.1	1.48E-11	Diastolic blood pressure	
SARC	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.58	6.38	9.44E-10	Diastolic blood pressure	
SARC	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.58	6.38	9.44E-10	Diastolic blood pressure	
SARC	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.58	6.76	1.06E-10	Diastolic blood pressure	
SARC	cis	1	rs9856693	chr3:134306913	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.45E-6	Height	
SARC	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.6	6.87	5.65E-11	Diastolic blood pressure	
SARC	cis	1	rs9863786	chr3:134247203	CEP63	chr3:134204575-134293852:+	0.34	4.86	2.13E-6	Height	
SARC	cis	1	rs9863915	chr3:41762002	ULK4	chr3:41288091-42003660:-	0.62	7.01	2.55E-11	Diastolic blood pressure	
SARC	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.57	5.7	3.56E-8	Diastolic blood pressure	
SARC	cis	1	rs9864346	chr3:134312352	CEP63	chr3:134204575-134293852:+	0.33	4.83	2.45E-6	Height	
SARC	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.27	-5.71	3.35E-8	Longevity	
SARC	cis	1	rs9864439	chr3:134298671	CEP63	chr3:134204575-134293852:+	0.33	4.85	2.25E-6	Height	
SARC	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	0.61	7.1	1.48E-11	Diastolic blood pressure	
SARC	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs9866759	chr3:41758418	ULK4	chr3:41288091-42003660:-	0.62	7.06	1.85E-11	Diastolic blood pressure	
SARC	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.6	-6.29	1.54E-9	Diastolic blood pressure	
SARC	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.61	6.99	2.8E-11	Diastolic blood pressure	
SARC	cis	1	rs9869282	chr3:41756064	ULK4	chr3:41288091-42003660:-	0.62	6.96	3.45E-11	Diastolic blood pressure	
SARC	cis	1	rs9869440	chr3:41763155	ULK4	chr3:41288091-42003660:-	0.6	6.77	1.04E-10	Diastolic blood pressure	
SARC	cis	1	rs9869981	chr3:134248801	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs9871305	chr3:134213538	CEP63	chr3:134204575-134293852:+	0.35	5.13	5.96E-7	Height	
SARC	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.53	5.53	8.41E-8	Diastolic blood pressure	
SARC	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.58	5.87	1.46E-8	Diastolic blood pressure	
SARC	cis	1	rs9874975	chr3:41764300	ULK4	chr3:41288091-42003660:-	0.62	7.02	2.38E-11	Diastolic blood pressure	
SARC	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.56	5.59	6.38E-8	Diastolic blood pressure	
SARC	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.59	6.74	1.24E-10	Diastolic blood pressure	
SARC	cis	1	rs9876658	chr3:134179453	CEP63	chr3:134204575-134293852:+	-0.29	-4.5	1.06E-5	Height	
SARC	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.25	-5.24	3.59E-7	Longevity	
SARC	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-0.58	-6.84	6.68E-11	Diastolic blood pressure	
SARC	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.26	-5.52	8.79E-8	Longevity	
SARC	cis	1	rs9882329	chr3:41767154	ULK4	chr3:41288091-42003660:-	0.61	6.93	3.95E-11	Diastolic blood pressure	
SARC	cis	1	rs9883753	chr3:134247231	CEP63	chr3:134204575-134293852:+	0.33	4.86	2.16E-6	Height	
SARC	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.26	-5.58	6.65E-8	Longevity	
SARC	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.25	-5.2	4.38E-7	Longevity	
SARC	cis	1	rs9884031	chr3:134256500	CEP63	chr3:134204575-134293852:+	0.34	4.95	1.4E-6	Height	
SARC	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.57	8.53	1.86E-15	Eye color traits	
SARC	cis	1	rs9921222	chr16:375782	RGS11	chr16:318310-325914:-	0.25	4.11	5.4E-5	Bone mineral density (spine);Bone mineral density	
SARC	cis	1	rs9921338	chr16:11416839	C16orf75	chr16:11343506-11445617:+	-0.31	-5.24	3.58E-7	Vein graft stenosis in coronary artery bypass grafting	
SARC	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.3	-4.08	6.23E-5	Height	
SARC	cis	1	rs9968172	chr3:134231251	CEP63	chr3:134204575-134293852:+	-0.35	-5.11	6.83E-7	Height	
SARC	cis	1	rs997872	chr22:25878614	CRYBB2	chr22:25615612-25627836:+	0.84	7.65	5.13E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs997873	chr22:25878282	CRYBB2	chr22:25615612-25627836:+	0.84	7.74	2.96E-13	Bipolar disorder with mood-incongruent psychosis	
SARC	cis	1	rs9985356	chr3:134232920	CEP63	chr3:134204575-134293852:+	-0.33	-4.84	2.4E-6	Height	
SARC	cis	1	rs9989967	chr3:134238964	CEP63	chr3:134204575-134293852:+	0.33	4.95	1.43E-6	Height	
SARC	cis	1	rs9990351	chr3:134239191	CEP63	chr3:134204575-134293852:+	-0.32	-4.72	4.14E-6	Height	
SARC	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.27	-5.91	1.23E-8	Longevity	
SARC	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.59	8.66	7.74E-16	Educational attainment	
SARC	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.56	8.03	4.79E-14	Educational attainment	
SARC	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.53	7.64	5.66E-13	Educational attainment	
SARC	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.47E-16	Educational attainment	
SARC	trans	1	rs10816359	chr9:108757670	SIX5	chr19:46268044-46272497:-	-0.49	-6.36	1.08E-9	Menarche (age at onset)	
SARC	trans	1	rs10839171	chr11:48923034	FOLH1B	chr11:89392465-89431885:+	0.43	6.3	1.48E-9	HDL cholesterol	
SARC	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.57	8.42	3.85E-15	Educational attainment	
SARC	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.57	8.42	3.85E-15	Educational attainment	
SARC	trans	1	rs10992221	chr9:94832043	CHST10	chr2:101008323-101034091:-	0.53	6.23	2.17E-9	Bipolar disorder and schizophrenia	
SARC	trans	1	rs11158293	chr14:61109020	ZNF716	chr7:57509883-57533265:+	-0.49	-6.13	3.61E-9	Gut microbiota (bacterial taxa)	
SARC	trans	1	rs113685916	chr9:117607150	CT47A10	chrX:120082278-120085594:-;chrX	0.21	6.77	1.02E-10	Ulcerative colitis or Crohn's disease	
SARC	trans	1	rs117517456	chr7:18488963	CT47A10	chrX:120082278-120085594:-;chrX	0.22	6.76	1.12E-10	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	
SARC	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.57	8.42	3.85E-15	Educational attainment	
SARC	trans	1	rs12293522	chr11:49558425	FOLH1B	chr11:89392465-89431885:+	-0.52	-7.76	2.6E-13	Height	
SARC	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.58	8.51	2.17E-15	Educational attainment	
SARC	trans	1	rs13021864	chr2:60108987	NFAM1	chr22:42776415-42828401:-	0.56	6.5	4.82E-10	Number of children (6+ vs. 0 or 1)	
SARC	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.49	-7.03	2.19E-11	Educational attainment	
SARC	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.58	8.44	3.33E-15	Educational attainment	
SARC	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.58	8.48	2.51E-15	Educational attainment	
SARC	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.47E-16	Educational attainment	
SARC	trans	1	rs16931910	chr9:117618309	CT47A10	chrX:120082278-120085594:-;chrX	0.22	6.8	8.84E-11	Ulcerative colitis or Crohn's disease	
SARC	trans	1	rs1809986	chr11:48987539	FOLH1B	chr11:89392465-89431885:+	-0.44	-6.41	7.78E-10	HDL cholesterol	
SARC	trans	1	rs1814175	chr11:49559172	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.41	2.3E-12	Height	
SARC	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.57	8.27	1.03E-14	Educational attainment	
SARC	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.47E-16	Educational attainment	
SARC	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.47E-16	Educational attainment	
SARC	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.53	7.64	5.66E-13	Educational attainment	
SARC	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.58	8.53	1.82E-15	Educational attainment	
SARC	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.53	7.64	5.71E-13	Educational attainment	
SARC	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.57	8.42	3.85E-15	Educational attainment	
SARC	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.57	8.42	3.85E-15	Educational attainment	
SARC	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.53	7.64	5.66E-13	Educational attainment	
SARC	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.53	7.64	5.66E-13	Educational attainment	
SARC	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.53	7.71	3.67E-13	Educational attainment	
SARC	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.58	8.53	1.84E-15	Educational attainment	
SARC	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.58	8.48	2.51E-15	Educational attainment	
SARC	trans	1	rs4929903	chr11:48913332	FOLH1B	chr11:89392465-89431885:+	-0.42	-6.27	1.71E-9	HDL cholesterol	
SARC	trans	1	rs62576736	chr9:108757205	SIX5	chr19:46268044-46272497:-	-0.48	-6.36	1.08E-9	Menarche (age at onset)	
SARC	trans	1	rs641862	chr13:110790232	ABHD13	chr13:108870763-108886602:+	0.7	6.36	1.02E-9	Obesity-related traits	
SARC	trans	1	rs641862	chr13:110790232	ARGLU1	chr13:107195664-107220514:-	0.51	6.19	2.74E-9	Obesity-related traits	
SARC	trans	1	rs641862	chr13:110790232	CUL4A	chr13:113863086-113919391:+	0.87	7.35	3.35E-12	Obesity-related traits	
SARC	trans	1	rs641862	chr13:110790232	LAMP1	chr13:113951469-113977741:+	0.73	6.75	1.15E-10	Obesity-related traits	
SARC	trans	1	rs641862	chr13:110790232	PCID2	chr13:113831925-113863029:-	0.8	6.42	7.5E-10	Obesity-related traits	
SARC	trans	1	rs641862	chr13:110790232	TUBGCP3	chr13:113139328-113242481:-	0.78	7.58	8.09E-13	Obesity-related traits	
SARC	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.43E-16	Educational attainment	
SARC	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.43E-16	Educational attainment	
SARC	trans	1	rs6545763	chr2:60112144	NFAM1	chr22:42776415-42828401:-	0.54	6.33	1.27E-9	Number of children (6+ vs. 0 or 1)	
SARC	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.52	7.47	1.57E-12	Educational attainment	
SARC	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.53	7.71	3.67E-13	Educational attainment	
SARC	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.58	-8.65	8.52E-16	Educational attainment	
SARC	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.47E-16	Educational attainment	
SARC	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.53	7.71	3.67E-13	Educational attainment	
SARC	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.47E-16	Educational attainment	
SARC	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.52	7.47	1.57E-12	Educational attainment	
SARC	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.58	8.53	1.82E-15	Educational attainment	
SARC	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.47E-16	Educational attainment	
SARC	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.58	8.48	2.51E-15	Educational attainment	
SARC	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.58	8.45	3.12E-15	Educational attainment	
SARC	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.58	8.45	3.12E-15	Educational attainment	
SARC	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.58	8.53	1.82E-15	Educational attainment	
SARC	trans	1	rs7852067	chr9:94815594	CHST10	chr2:101008323-101034091:-	-0.54	-6.24	1.99E-9	Bipolar disorder and schizophrenia	
SARC	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.54	-7.72	3.43E-13	Educational attainment	
SARC	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.5	7.12	1.3E-11	Educational attainment	
SARC	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.53	7.64	5.66E-13	Educational attainment	
SARC	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.53	7.71	3.67E-13	Educational attainment	
SARC	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.56	8.17	1.95E-14	Educational attainment	
SARC	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.57	8.42	3.85E-15	Educational attainment	
SARC	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.53	7.64	5.66E-13	Educational attainment	
SARC	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.58	8.53	1.82E-15	Educational attainment	
SARC	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.52	7.47	1.57E-12	Educational attainment	
SARC	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.53	7.64	5.66E-13	Educational attainment	
SARC	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.57	8.42	3.85E-15	Educational attainment	
SARC	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.57	-8.38	5.0E-15	Educational attainment	
SARC	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.58	8.48	2.51E-15	Educational attainment	
SARC	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.53	7.68	4.28E-13	Educational attainment	
SARC	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.58	8.53	1.82E-15	Educational attainment	
SARC	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.59	-8.53	1.8E-15	Educational attainment	
SARC	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.47E-16	Educational attainment	
SARC	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.61	8.91	1.47E-16	Educational attainment	
SARC	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.59	8.68	6.91E-16	Educational attainment	
